rfhg_137427.1

Basic information about the TSS

---

TSS ID: rfhg_137427.1 Species: human Chr: chr11		Start: 60922318 End: 60922342 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AF131803:-107 GeneID: 79073 HGNC/MGI_ID: HGNC:28771 UniProt_ID: Nearer transcript ids and distances: LF345063:-108 MA580640:-108 LF345064:-260 MA580641:-260 LF345062:263 MA580639:263 ENST00000540280.1:276 view more...

Gene_name: transmembrane protein 109 Gene_symbol: TMEM109 Gene_synonyms: MGC5508 Gene_source: HGNC:28771

TATA-Box annotation

---

Distance to TSS:	-2130
Nearest PromoterID:	NM_017870
Entrez ID:	54972
Nearest Unigene:	Hs.118552
Nearest Refseq:	NM_017870
Nearest Ensembl:	ENSG00000006118
Gene Name:	transmembrane protein 109
Gene Alias:	GBP|HSPA5BP1
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.560000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TMEM109 p2@TMEM109 p3@TMEM109 p4@TMEM109 p5@TMEM109 p6@TMEM109
Sample		p1@TMEM109	p2@TMEM109	p3@TMEM109	p4@TMEM109	p5@TMEM109	p6@TMEM109
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	75.78	6.82	10.52	0.19	1.17	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	74.25	6.47	13.15	1.21	1.82	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	78.32	7.14	11.19	1.35	2.51	0.77
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	65.08	5.41	9.15	1.25	2.29	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	71.76	7.42	11.70	0.45	0.90	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	77.91	6.01	12.79	1.74	1.74	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	90.64	7.63	8.28	1.53	0.87	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	86.96	6.30	8.24	1.94	2.18	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	94.25	7.48	10.04	1.92	2.56	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	37.10	2.90	6.96	0.58	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	36.38	2.83	6.47	0.81	0.81	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	36.18	2.44	5.29	1.22	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	26.60	2.10	1.13	0.16	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	26.16	2.41	0.75	0.15	0.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	25.03	2.42	0.66	0.00	0.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	23.89	2.77	0.50	0.25	1.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	24.24	3.49	0.00	0.44	1.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	22.36	0.84	0.42	0.42	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	26.12	1.07	2.13	0.53	2.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	26.18	2.41	0.30	0.15	0.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	28.87	1.74	0.67	0.00	1.34	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	27.96	2.93	0.86	0.69	1.04	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	24.69	1.55	0.52	0.00	0.78	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	26.21	1.94	0.97	0.24	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	25.80	3.35	1.29	0.26	1.03	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	25.00	2.85	0.00	0.32	0.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	24.73	3.85	0.55	0.00	1.10	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	26.64	1.65	0.24	0.94	1.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	27.62	2.42	1.29	0.16	1.29	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	27.69	1.63	1.27	0.00	1.45	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	24.70	3.56	0.21	0.00	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	25.01	2.54	0.98	0.59	1.37	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	29.12	2.95	0.00	0.21	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	31.83	3.13	1.65	0.16	1.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	29.17	2.62	0.56	0.93	0.75	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	26.25	1.72	0.57	0.77	1.53	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	24.53	2.04	1.43	0.00	2.25	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	24.78	2.82	0.40	0.20	1.01	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	29.17	2.97	0.81	0.00	1.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	22.33	4.56	0.72	0.00	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	24.23	3.29	1.65	0.71	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	34.55	2.64	0.44	0.15	1.76	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	30.37	4.43	0.42	0.63	1.69	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	27.62	4.20	0.70	0.17	1.40	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	32.53	2.81	0.20	0.20	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	29.31	1.86	0.70	0.23	1.86	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	29.99	2.16	0.48	0.00	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	30.40	4.17	0.30	0.00	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	31.84	2.63	0.24	0.24	1.20	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	38.01	3.03	0.61	0.00	1.62	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	34.23	3.48	1.64	0.41	1.23	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	36.69	6.23	0.67	0.22	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	30.52	3.55	0.35	0.35	1.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	33.47	3.65	0.66	0.00	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	26.01	0.00	0.84	0.84	2.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	37.66	3.21	0.00	0.00	2.30	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	33.71	3.24	0.32	0.32	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	24.73	2.57	0.32	0.00	0.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	38.03	2.20	1.57	0.31	1.57	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	19.04	4.94	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	20.19	3.93	0.56	0.00	1.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	22.29	4.78	0.00	0.00	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	23.10	2.72	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	19.17	3.90	0.97	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	22.01	3.55	0.00	0.00	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	26.81	3.90	1.46	0.00	0.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	27.27	2.98	1.49	0.00	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	27.21	2.35	2.81	0.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	39.08	3.64	0.99	0.33	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	34.03	4.95	0.62	0.00	2.47	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	31.80	2.75	0.31	0.31	0.61	0.00
Adipocyte - breast, donor1	11376-118A8	100.57	16.95	4.12	1.43	3.17	1.27
Adipocyte - breast, donor2	11327-117E4	60.80	8.02	2.25	0.32	0.96	0.64
Adipocyte - omental, donor1	11473-119C6	87.02	15.52	4.07	1.40	2.93	0.64
Adipocyte - omental, donor2	11474-119C7	82.22	8.97	5.23	0.75	1.49	2.24
Adipocyte - omental, donor3	11475-119C8	65.64	8.04	4.02	1.34	1.34	0.67
Adipocyte - perirenal, donor1	11476-119C9	54.23	10.21	2.55	2.55	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	21.99	5.50	2.20	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	83.55	6.32	1.81	0.45	5.87	1.35
Adipocyte - subcutaneous, donor3	11408-118E4	71.94	12.16	1.39	0.35	2.26	0.52
Adipocyte differentiation, day04, donor1	13019-139D4	43.81	6.26	2.35	1.76	0.98	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	20.08	7.46	0.51	1.54	0.26	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	39.31	8.92	1.67	0.84	0.00	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	37.03	5.29	1.18	1.76	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	42.55	6.19	1.21	0.48	0.80	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	41.64	6.13	0.32	0.32	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	29.86	6.93	1.07	0.53	0.00	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	37.28	6.12	2.78	0.56	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	42.42	6.65	2.50	0.83	0.00	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	39.18	4.02	2.01	0.00	0.25	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	40.58	5.24	2.95	0.98	0.98	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	27.71	3.96	1.83	0.30	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	62.54	6.63	3.09	1.10	0.00	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	121.20	9.32	4.66	3.59	1.08	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	40.73	7.19	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	87.97	6.30	7.56	3.42	0.18	1.26
Amniotic Epithelial Cells, donor2	11613-122A2	76.98	6.69	11.71	5.02	3.35	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	78.07	4.11	4.31	2.67	0.62	0.41
Anulus Pulposus Cell, donor1	11248-116E6	44.74	5.38	1.95	0.46	0.57	0.92
Anulus Pulposus Cell, donor2	11463-119B5	30.37	5.14	1.71	0.24	0.24	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	20.67	6.29	0.45	0.45	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	25.61	4.78	1.30	0.00	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	23.54	4.28	2.14	2.14	4.28	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	25.71	5.08	0.60	0.60	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	16.44	5.06	0.00	1.26	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	15.84	5.94	2.64	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	21.44	4.22	0.97	0.65	0.00	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	23.79	3.88	0.97	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	24.35	3.56	0.00	0.00	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	22.22	4.52	1.88	0.00	0.00	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	20.32	2.90	1.45	1.45	0.00	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	15.05	2.51	2.51	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	26.19	4.12	1.32	0.49	0.16	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	15.01	0.00	2.73	0.00	1.36	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	20.06	3.47	0.75	0.15	0.00	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	28.93	3.21	1.61	0.00	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	27.02	3.59	0.57	0.57	0.38	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	21.38	5.35	0.80	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	21.46	5.85	0.98	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	27.37	5.64	0.50	0.00	0.00	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	21.61	4.80	0.00	0.00	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	35.40	3.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	28.30	4.80	0.86	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	4.19	0.00	0.00	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	30.10	3.88	0.49	0.49	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	27.70	4.17	0.76	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	25.44	9.69	1.21	0.00	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	23.37	6.27	1.14	0.57	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	28.43	6.20	0.64	0.21	0.00	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	21.68	5.16	1.55	0.00	0.00	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	22.52	2.35	2.35	0.00	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	24.12	2.89	0.00	0.00	0.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	22.83	6.42	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	23.98	3.51	1.17	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	22.58	5.42	0.90	0.60	0.30	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	11.88	5.94	1.19	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	27.46	4.58	0.51	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	28.02	4.84	1.02	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	10.80	6.99	0.64	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	22.44	3.88	0.43	0.00	0.00	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	24.34	2.75	0.42	0.64	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	18.56	3.77	0.87	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	22.67	1.89	0.00	0.00	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	20.85	4.58	0.51	0.17	0.00	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	32.43	4.63	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	25.35	6.34	2.11	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	23.37	4.93	0.43	0.21	0.21	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	26.47	7.22	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	28.43	5.10	3.64	0.00	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	25.52	5.29	0.69	0.69	0.00	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	22.95	2.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	14.49	4.83	1.02	0.25	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	30.14	4.34	0.83	0.41	0.00	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	18.97	3.06	0.61	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	22.94	4.78	1.43	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	27.72	3.33	0.67	0.44	0.00	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	19.84	3.05	1.53	1.53	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	27.69	3.32	1.11	0.55	0.00	1.66
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	23.83	3.71	0.26	0.00	0.26	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	20.35	4.00	0.73	0.73	0.36	0.36
Astrocyte - cerebellum, donor1	11500-119F6	59.20	7.25	2.58	1.35	0.12	0.98
Astrocyte - cerebellum, donor2	11580-120F5	69.66	10.10	1.54	1.03	0.68	0.68
Astrocyte - cerebellum, donor3	11661-122F5	29.36	4.82	1.89	0.63	0.42	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	27.19	3.49	0.35	0.35	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	32.52	5.01	2.10	0.49	0.16	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	41.32	4.77	2.09	0.60	0.00	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	45.42	2.18	2.29	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	49.86	4.01	1.88	0.00	0.38	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	44.84	2.50	1.25	0.00	0.34	0.00
Basophils, donor1	12241-129G9	34.00	2.62	2.09	0.52	0.00	0.00
Basophils, donor2	12242-129H1	32.83	3.97	2.16	0.00	0.00	0.00
Basophils, donor3	12243-129H2	38.22	1.76	0.59	0.29	0.29	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	27.60	0.86	1.29	0.00	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	42.52	3.66	0.91	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	7.17	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	21.97	2.51	0.63	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	29.32	1.25	0.83	0.42	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	5.99	1.38	0.23	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	18.89	1.08	0.00	0.00	0.00	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	73.07	1.55	2.16	0.10	0.21	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	74.53	1.86	2.33	0.23	0.23	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	62.04	5.44	2.88	0.32	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	33.81	2.25	1.69	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	27.84	2.41	1.30	0.00	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	31.61	1.32	0.88	0.22	0.22	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	52.36	5.94	1.42	0.28	0.28	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	41.32	1.52	1.90	0.38	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	33.20	2.30	0.66	0.33	0.66	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	17.06	0.87	1.01	0.29	0.14	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	12.07	0.30	0.30	0.00	0.91	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	19.90	1.66	0.95	0.71	0.47	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	8.70	0.33	0.50	0.33	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	9.38	0.55	0.83	0.00	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	9.42	0.25	0.99	0.25	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	13.51	0.98	0.59	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	16.02	1.78	1.07	0.18	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	20.02	1.96	1.52	0.22	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	9.13	0.47	0.70	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	13.73	0.53	1.06	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	18.86	3.33	1.11	0.00	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	9.82	1.04	1.19	0.00	0.15	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	10.38	1.00	0.40	0.00	0.20	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	9.37	1.67	1.25	0.83	0.21	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	10.07	0.92	2.29	0.00	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	12.22	0.90	1.81	0.23	0.68	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	10.48	0.87	2.18	0.44	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	22.33	1.61	1.88	0.27	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	31.40	2.62	2.27	0.35	1.05	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	36.61	2.52	5.05	0.42	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	7.35	0.73	0.73	0.37	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	6.69	0.35	1.06	0.00	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	9.65	0.88	0.88	0.00	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	11.86	1.22	0.35	0.35	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	17.10	0.74	0.74	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	17.68	1.08	1.72	0.00	0.65	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	13.51	1.23	1.23	0.41	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	9.27	0.70	1.16	0.00	0.00	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	7.19	1.16	1.62	0.46	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	30.08	2.40	1.31	0.22	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	33.96	1.85	1.39	0.23	0.46	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	29.46	2.38	0.65	0.43	0.43	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	47.65	2.96	1.40	0.62	0.16	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	41.74	3.32	1.22	0.17	0.00	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	23.41	2.23	1.56	0.22	0.45	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	19.90	2.30	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	27.45	1.76	1.54	0.00	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	24.00	1.47	0.84	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	56.90	2.03	2.03	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	77.97	2.03	2.03	0.68	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	64.21	5.18	6.21	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	78.89	4.26	3.20	0.00	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	88.45	1.61	2.14	0.00	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	63.88	4.91	4.21	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	58.04	5.49	3.92	0.78	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	68.55	5.27	6.59	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	55.89	4.93	1.64	0.00	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	40.62	2.90	2.18	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	36.35	1.01	1.01	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	65.46	4.44	1.62	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	51.53	3.99	2.00	0.40	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	8.03	3.01	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	12.36	0.00	0.00	0.56	0.00	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	104.46	6.39	4.88	1.13	0.38	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	92.22	4.96	3.16	0.45	0.45	0.00
CD4+ T Cells, donor1	11225-116C1	46.77	1.07	1.79	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	48.38	3.06	1.22	0.61	1.84	0.00
CD4+ T Cells, donor3	11382-118B5	60.39	1.83	1.83	0.30	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	53.60	3.32	5.10	0.26	1.02	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	64.46	3.14	2.47	0.00	0.67	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	51.74	3.45	4.31	0.29	1.15	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	48.83	2.84	1.42	0.00	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	56.19	2.81	5.62	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	39.55	0.00	6.59	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	48.12	1.59	2.46	0.14	0.43	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	60.16	2.71	2.03	0.00	0.85	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	57.71	1.77	2.74	0.00	0.64	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	52.45	3.14	6.72	0.45	0.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	61.14	2.45	3.84	0.35	0.35	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	50.16	2.20	5.72	0.00	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	52.71	1.69	5.90	0.00	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	54.64	2.70	1.66	0.00	0.62	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	48.45	2.34	1.67	0.00	0.33	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	68.80	3.26	3.81	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	69.14	5.36	4.29	0.00	1.07	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	50.21	0.00	5.38	0.00	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	64.34	1.30	6.68	0.19	0.74	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	83.61	1.52	4.98	0.00	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	75.86	3.15	2.73	0.00	0.42	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	62.69	1.01	5.56	0.00	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	81.45	4.77	4.33	0.00	1.30	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	88.47	4.79	4.79	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	100.95	3.46	4.45	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	81.24	2.77	5.54	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	75.37	5.58	1.40	0.00	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	85.85	3.88	6.65	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	108.46	4.66	7.36	0.00	1.23	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	84.70	7.70	10.78	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	110.30	5.37	6.09	0.36	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	102.49	4.15	6.92	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	76.94	1.31	0.98	0.00	0.65	0.00
CD8+ T Cells, donor2	11307-117C2	70.58	1.50	1.88	0.00	0.38	0.00
CD8+ T Cells, donor3	11383-118B6	65.39	2.27	2.78	0.00	0.76	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	76.85	5.73	4.36	0.46	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	73.09	6.71	5.03	0.24	0.24	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	74.69	7.11	6.02	0.27	0.27	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	119.78	7.21	4.80	0.30	0.60	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	101.99	6.48	4.56	0.48	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	71.17	6.14	5.00	0.45	1.36	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	72.79	5.00	5.00	0.22	0.22	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	75.01	3.42	5.53	0.26	0.53	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	75.98	3.05	6.33	0.23	0.47	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	67.32	5.13	3.62	0.30	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	70.59	2.32	4.65	0.58	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	69.81	3.46	3.73	0.00	0.80	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	32.83	3.50	1.75	0.00	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	32.79	1.82	3.64	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	26.11	1.49	0.00	0.75	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	74.91	6.84	6.48	0.36	2.88	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	95.24	4.03	4.89	0.29	1.44	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	72.83	5.66	4.24	0.00	1.65	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	91.27	4.75	3.80	0.32	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	83.66	5.54	4.61	0.00	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	83.03	5.13	5.77	0.32	1.60	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	63.49	4.21	4.59	0.38	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	65.03	5.12	4.34	0.00	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	63.54	1.51	2.27	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	45.77	0.80	2.41	0.00	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	57.35	3.50	2.10	0.00	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	44.08	5.01	5.01	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	16.45	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	30.14	7.91	1.48	0.49	0.49	0.99
Cardiac Myocyte, donor3	11686-122I3	56.30	11.79	2.00	0.84	0.11	0.84
Chondrocyte - de diff, donor1	11261-116G1	78.35	4.85	4.16	1.04	2.77	0.35
Chondrocyte - de diff, donor2	11338-117F6	55.44	12.44	2.49	1.78	0.36	1.78
Chondrocyte - de diff, donor3	11410-118E6	54.84	7.96	2.16	1.14	0.91	0.23
Chondrocyte - re diff, donor2	11339-117F7	29.54	2.69	0.90	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	34.78	5.26	1.21	0.40	0.00	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	38.90	5.28	1.26	0.69	0.23	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	29.29	8.34	1.07	0.86	0.00	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	29.29	6.02	0.88	0.35	0.18	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	78.31	15.77	3.58	1.74	0.55	0.55
Corneal Epithelial Cells, donor1	11526-119I5	32.94	2.42	1.10	0.22	0.44	0.22
Corneal Epithelial Cells, donor2	11606-120I4	40.95	0.00	3.41	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	31.70	2.56	2.05	0.51	0.51	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	18.66	2.48	0.33	0.33	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	26.81	2.84	0.32	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	20.70	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	30.99	2.05	0.76	0.97	0.22	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	272.63	6.83	11.27	0.34	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	193.90	4.57	7.18	0.65	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	220.19	3.87	9.68	0.48	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	101.73	21.18	3.67	0.50	0.00	1.83
Endothelial Cells - Aortic, donor1	11263-116G3	62.79	13.50	1.76	0.59	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	89.65	16.12	2.26	0.85	0.00	1.98
Endothelial Cells - Aortic, donor3	11412-118E8	52.29	19.66	0.39	0.00	0.00	1.18
Endothelial Cells - Artery, donor1	11264-116G4	101.22	17.45	1.75	0.29	1.75	0.00
Endothelial Cells - Artery, donor2	11341-117F9	140.46	29.41	3.06	0.94	1.18	1.65
Endothelial Cells - Artery, donor3	11413-118E9	110.09	24.89	1.75	0.88	0.53	2.45
Endothelial Cells - Lymphatic, donor1	11236-116D3	67.60	15.52	1.77	0.44	0.22	0.89
Endothelial Cells - Lymphatic, donor2	11317-117D3	61.16	11.26	2.13	0.00	0.61	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	59.48	11.84	0.56	0.00	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	93.00	17.23	1.78	0.30	2.38	1.49
Endothelial Cells - Microvascular, donor2	11342-117G1	70.81	9.37	1.04	0.00	0.52	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	70.61	18.15	0.85	0.28	1.99	1.70
Endothelial Cells - Thoracic, donor1	11266-116G6	114.83	22.01	4.00	0.80	2.80	4.00
Endothelial Cells - Thoracic, donor2	11343-117G2	90.15	19.39	0.52	1.05	2.62	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	101.51	28.08	3.98	0.99	1.24	4.60
Endothelial Cells - Umbilical vein, donor2	11324-117E1	58.88	24.77	0.87	0.43	0.22	1.30
Endothelial Cells - Umbilical vein, donor3	11400-118D5	69.98	21.74	0.73	0.12	0.12	1.47
Endothelial Cells - Vein, donor1	11267-116G7	114.89	22.75	2.28	0.00	1.14	2.28
Endothelial Cells - Vein, donor2	11344-117G3	106.87	22.35	3.49	3.49	0.70	2.10
Endothelial Cells - Vein, donor3	11416-118F3	103.78	25.59	3.14	0.79	0.16	2.51
Eosinophils, donor1	12244-129H3	30.49	0.00	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	3.30	0.00	6.60	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	10.70	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	20.28	1.22	0.73	0.24	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	37.44	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	43.93	4.11	0.41	0.00	0.41	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	27.15	4.16	0.99	0.00	2.19	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	6.28	2.06	1.63	0.54	0.65	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	53.36	7.40	2.67	0.36	2.06	0.97
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	33.84	5.73	0.96	0.55	0.00	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	33.96	5.70	0.84	0.32	1.37	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	112.51	12.65	2.11	0.53	4.22	1.58
Fibroblast - Aortic Adventitial, donor3	11401-118D6	50.16	9.97	1.99	0.00	1.66	1.00
Fibroblast - Cardiac, donor1	11268-116G8	34.48	5.44	1.36	0.91	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	46.99	8.34	1.52	1.52	0.76	1.52
Fibroblast - Cardiac, donor3	11417-118F4	56.30	8.04	2.52	0.79	1.10	0.79
Fibroblast - Cardiac, donor4	11452-119A3	26.07	3.94	0.91	0.61	0.30	0.30
Fibroblast - Cardiac, donor5	11456-119A7	51.65	8.63	1.52	0.89	0.63	1.14
Fibroblast - Cardiac, donor6	11460-119B2	65.49	8.19	1.52	0.45	0.61	1.21
Fibroblast - Choroid Plexus, donor1	11492-119E7	70.21	9.38	2.55	1.07	1.21	0.94
Fibroblast - Choroid Plexus, donor2	11572-120E6	43.14	10.35	1.73	0.43	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	62.99	7.32	2.93	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	65.50	8.53	2.54	2.08	0.46	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	61.74	7.97	2.54	1.36	0.34	0.17
Fibroblast - Dermal, donor1	11269-116G9	43.67	6.57	0.94	0.00	1.88	0.23
Fibroblast - Dermal, donor2	11346-117G5	64.15	5.19	3.30	0.00	0.47	0.47
Fibroblast - Dermal, donor3	11418-118F5	52.83	6.77	1.45	0.73	1.09	0.36
Fibroblast - Dermal, donor4	11450-119A1	45.44	4.30	1.36	0.11	0.11	0.68
Fibroblast - Dermal, donor5	11454-119A5	62.28	7.50	1.05	1.05	0.00	0.35
Fibroblast - Dermal, donor6	11458-119A9	74.39	7.63	2.27	0.81	0.16	0.49
Fibroblast - Gingival, donor1	11237-116D4	40.81	4.58	1.25	1.04	0.00	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	47.95	5.76	0.52	1.31	1.05	0.79
Fibroblast - Gingival, donor2	11318-117D4	87.24	6.85	2.50	1.45	0.13	1.45
Fibroblast - Gingival, donor3	11394-118C8	30.84	4.35	0.77	0.39	0.10	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	48.83	11.43	1.04	1.04	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	35.95	4.05	1.23	0.35	1.06	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	52.23	6.86	1.56	0.62	0.47	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	62.61	5.81	2.30	0.41	0.54	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	79.75	7.41	1.41	0.71	0.71	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	43.87	4.68	1.75	0.88	0.15	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	66.68	7.50	2.45	0.82	0.27	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	77.88	7.90	2.74	0.55	0.88	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	38.59	7.34	1.32	0.73	1.61	0.73
Fibroblast - Lung, donor1	11270-116H1	44.86	4.08	1.36	0.00	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	44.76	10.45	1.49	1.49	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	77.45	8.02	1.27	1.27	0.84	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	111.62	9.16	12.50	0.83	0.83	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	57.34	5.59	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	38.06	6.72	1.96	0.28	0.56	0.00
Fibroblast - Mammary, donor1	11540-120B1	96.21	12.99	4.47	0.81	0.00	1.22
Fibroblast - Mammary, donor2	11620-122A9	95.86	3.99	0.00	0.00	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	59.56	11.91	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	66.92	8.53	3.30	0.78	0.19	1.36
Fibroblast - Periodontal Ligament, donor2	11319-117D5	73.11	7.13	2.43	1.06	0.00	1.06
Fibroblast - Periodontal Ligament, donor3	11395-118C9	57.22	4.59	2.14	0.31	0.61	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	36.25	4.20	1.14	0.38	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	39.96	7.02	2.16	0.54	0.27	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	35.84	6.15	0.81	0.12	0.70	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	102.91	10.72	3.32	0.88	0.44	0.99
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	91.64	8.94	2.64	0.81	0.20	0.81
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	74.17	9.35	2.00	0.67	0.00	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	41.12	4.74	1.98	0.79	0.79	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	106.57	11.51	2.98	0.40	0.40	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	42.10	5.51	1.95	0.36	0.00	0.71
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	36.46	4.73	1.77	0.99	0.39	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	112.52	11.13	3.31	1.20	0.00	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	35.62	4.43	1.84	1.19	0.22	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	44.29	3.29	1.27	0.00	0.51	0.00
Fibroblast - skin normal, donor1	11553-120C5	43.81	4.92	1.97	0.82	0.49	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	126.72	10.63	1.60	1.40	0.00	0.60
Fibroblast - skin normal, donor2	11561-120D4	35.66	3.62	2.71	0.90	0.00	0.60
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	51.38	8.76	2.12	1.51	1.81	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	38.27	6.13	2.15	0.83	0.41	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	46.67	6.50	2.39	0.85	0.85	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	92.95	12.81	2.96	0.33	0.00	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	59.33	5.01	3.52	0.96	0.53	0.43
Fibroblast - skin walker warburg, donor1	11554-120C6	66.63	6.41	2.19	1.52	0.00	1.01
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	48.14	5.02	3.45	1.73	1.25	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	40.09	3.49	0.00	0.00	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	25.48	1.39	0.69	0.00	0.35	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	25.76	1.30	0.26	0.00	0.26	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	24.02	1.02	1.28	0.00	0.26	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	19.14	2.30	1.53	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	21.69	2.55	0.64	0.64	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	23.68	3.99	3.42	0.57	3.14	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	26.75	4.14	0.55	0.83	9.38	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	17.81	1.60	0.68	0.68	5.02	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	20.80	3.17	1.59	0.40	3.17	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	26.70	2.64	1.85	0.79	8.72	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	16.96	4.89	0.98	0.00	4.89	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	14.59	3.10	1.33	0.44	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	19.93	1.98	0.71	0.14	0.42	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	23.15	2.46	1.35	0.37	0.49	0.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	22.03	1.34	1.07	0.27	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	53.27	6.19	1.61	0.62	0.74	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	34.74	3.74	0.83	0.97	0.42	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	18.50	2.85	0.81	0.00	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	36.51	6.16	2.28	0.91	1.83	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	33.26	4.48	1.12	0.50	0.75	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	26.88	4.81	1.53	0.22	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	49.94	7.39	1.18	0.00	1.18	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	47.53	5.09	1.59	0.32	1.75	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	35.75	4.92	1.34	0.22	0.67	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	46.38	5.85	2.42	1.41	1.21	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	53.95	6.28	1.19	1.02	0.85	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	62.43	8.42	2.31	1.68	1.68	0.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	66.49	8.12	4.06	2.08	1.04	1.14
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	63.19	7.17	4.10	1.54	2.05	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	51.68	5.86	1.77	0.44	0.55	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	54.83	6.82	2.83	1.25	1.08	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	53.50	5.51	2.86	0.82	0.41	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	55.08	6.60	2.06	1.24	1.03	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	54.53	5.76	2.31	1.04	0.69	0.46
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	60.54	6.17	3.00	1.50	0.67	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	46.29	5.29	2.42	1.32	1.76	0.88
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	61.13	6.27	2.71	0.98	0.74	0.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	48.30	7.29	3.40	0.65	1.13	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	52.60	6.74	1.92	0.96	0.64	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	48.70	5.59	1.90	0.66	1.14	0.66
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	48.72	5.69	3.64	1.11	0.63	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	48.35	5.47	3.34	0.91	2.43	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	54.57	5.85	1.78	1.46	1.46	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	47.64	3.73	1.54	0.88	0.66	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	45.45	5.61	4.21	0.56	1.68	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	56.85	7.50	2.22	1.02	0.74	0.93
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	52.68	9.09	1.87	1.87	0.53	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	61.66	7.19	2.45	1.38	0.61	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	66.71	7.51	2.20	0.39	0.52	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	50.69	7.05	2.71	0.81	2.17	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	66.18	6.45	3.87	1.84	0.92	1.11
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	59.43	7.90	1.75	1.32	0.88	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	51.57	6.94	4.96	1.98	0.99	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	71.36	9.10	3.43	1.19	1.19	0.92
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	69.40	8.47	3.23	1.82	1.41	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	73.20	11.18	5.34	1.52	0.51	1.02
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	13.14	2.39	1.39	0.60	0.20	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	17.26	2.00	0.15	0.15	0.31	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	27.21	2.45	2.25	0.20	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	35.05	5.01	1.56	1.88	0.94	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	27.41	2.54	3.11	0.28	0.28	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	17.53	1.38	0.46	0.46	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	29.70	2.47	0.00	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	31.33	3.09	2.32	0.77	1.55	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	40.11	1.60	0.00	0.00	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	39.99	8.69	3.48	3.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	24.41	4.23	2.28	0.65	1.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	28.41	3.29	1.65	0.82	0.82	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	33.32	3.33	6.66	0.00	6.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	38.59	4.75	3.92	0.56	0.84	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	33.34	4.58	1.96	1.96	1.31	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	47.81	0.84	0.00	0.00	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	34.67	5.09	1.27	1.91	1.59	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	27.85	1.36	1.36	1.02	2.04	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	29.23	4.18	0.00	2.09	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	37.23	2.29	2.29	0.57	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	29.60	3.55	2.37	0.89	1.48	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	37.27	5.08	1.69	0.00	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	40.59	6.63	2.90	1.24	0.83	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	42.11	4.83	2.30	2.07	1.15	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	26.34	5.27	0.00	0.00	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	25.37	5.00	1.92	0.77	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	26.40	4.89	0.98	0.33	1.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	25.42	6.02	0.67	0.00	2.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	39.68	5.01	2.70	0.39	2.31	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	39.71	4.45	2.74	0.68	1.37	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	22.36	4.97	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	25.01	3.77	0.47	1.42	3.77	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	31.99	4.22	1.81	1.21	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	28.99	4.58	0.51	0.51	3.05	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	28.72	5.98	0.00	1.99	1.20	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	37.00	3.95	0.99	0.00	0.00	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	27.15	1.18	1.18	1.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	28.59	3.50	0.58	0.00	2.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	24.14	1.32	2.63	0.44	0.44	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	22.04	3.39	0.85	1.70	0.85	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	32.23	4.18	0.60	0.00	1.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	34.45	1.94	1.46	0.97	1.46	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	54.78	4.57	3.42	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	38.26	6.24	1.66	0.42	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	75.34	7.87	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	36.47	3.17	1.59	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	41.77	3.76	0.00	0.42	0.42	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	59.30	4.06	2.55	0.81	0.23	0.70
Hep-2 cells mock treated, biol_rep2	11899-125E9	62.79	4.05	2.19	1.35	0.17	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	56.42	4.10	4.55	0.46	0.46	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	60.23	6.34	3.28	0.33	0.00	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	65.98	6.02	3.22	0.43	0.43	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	60.28	5.38	2.37	1.08	0.22	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	58.91	3.74	3.49	0.75	0.25	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	64.16	3.77	2.92	0.34	0.69	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	50.62	3.84	1.92	0.64	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	114.16	22.38	1.12	0.56	1.12	3.92
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	99.54	11.69	4.76	0.00	3.03	2.60
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	76.67	21.15	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	69.13	9.17	1.76	1.76	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	69.02	14.53	2.18	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	86.89	15.56	4.02	1.22	0.35	1.57
Hepatocyte, donor1	11523-119I2	31.48	7.26	1.21	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	35.55	2.15	0.00	0.00	1.08	0.00
Hepatocyte, donor3	11684-122I1	34.36	9.82	0.00	0.61	1.84	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	41.77	3.26	5.22	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	33.38	3.32	2.45	1.05	0.17	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	32.11	4.39	0.96	0.41	0.00	0.96
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	50.94	6.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	60.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	27.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	34.61	5.54	1.38	1.38	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	40.04	10.01	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	83.08	0.00	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	33.32	7.69	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	50.28	4.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	51.98	3.25	0.00	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	43.35	5.00	1.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	21.78	0.00	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	55.59	7.94	2.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	46.56	4.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	52.38	5.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	54.80	5.67	1.26	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	49.49	0.00	4.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	58.79	2.58	0.65	0.00	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	46.69	1.61	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	66.01	4.07	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	62.97	5.04	0.42	0.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	57.87	7.23	0.80	1.61	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	37.85	9.23	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	60.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	46.26	7.08	0.94	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	51.70	6.35	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	49.50	6.46	2.15	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	52.09	10.16	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	54.20	3.83	1.91	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	58.33	7.29	1.82	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	56.41	5.00	2.14	0.00	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	79.64	9.95	3.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	83.39	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	48.77	6.17	1.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	68.48	14.05	0.00	0.00	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	78.58	6.29	3.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	77.19	6.95	0.70	0.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	48.69	8.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	55.11	6.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	48.83	6.10	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	45.00	2.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	45.30	10.45	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	50.14	12.80	1.07	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	63.73	9.70	0.00	0.00	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	31.35	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	46.94	3.68	2.76	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	39.33	3.03	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	0.00	6.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	39.12	8.46	1.06	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	18.77	1.71	1.31	0.00	0.65	0.00
Keratinocyte - epidermal, donor2	11349-117G8	13.47	1.17	0.59	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	36.82	2.08	1.14	0.00	0.28	0.38
Keratinocyte - oral, donor1	11251-116E9	29.40	1.48	1.02	0.23	0.00	0.00
Keratocytes, donor1	11527-119I6	39.20	6.53	0.69	0.69	0.69	1.03
Keratocytes, donor2	11607-120I5	53.90	8.20	7.03	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	47.42	6.72	1.58	0.99	0.59	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	13.19	2.20	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	37.76	7.55	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	27.68	2.54	0.69	0.00	0.00	0.00
Lens Epithelial Cells, donor3	11690-122I7	35.02	5.75	0.50	0.61	0.10	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	70.67	21.58	0.95	0.59	0.95	1.42
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	59.16	25.12	1.67	0.56	2.23	1.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	71.15	24.71	3.15	0.47	0.63	1.73
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	49.47	19.36	0.54	0.00	0.54	2.69
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	55.47	20.80	1.89	0.32	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	54.55	21.35	1.40	0.43	0.32	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	52.12	19.29	0.00	0.82	0.41	1.64
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	71.80	26.55	1.52	0.51	1.01	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	60.94	22.66	1.97	0.28	0.84	0.70
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	42.72	14.24	1.19	0.79	0.40	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	59.52	18.81	1.94	0.39	0.58	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	58.88	23.70	1.11	0.19	0.93	1.30
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	50.52	17.07	0.70	0.35	0.00	3.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	71.32	24.09	1.19	0.48	0.48	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	68.40	20.60	1.24	0.27	1.10	1.79
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	50.51	16.94	0.62	0.31	0.00	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	67.96	26.19	1.56	0.31	1.56	1.25
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	70.82	28.36	2.38	0.37	0.73	2.38
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	44.43	22.05	2.30	0.33	0.00	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	72.63	29.29	1.76	1.17	0.88	1.46
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	77.67	27.63	2.49	0.75	0.00	1.49
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	50.92	18.91	1.45	0.00	0.48	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	63.02	22.08	1.08	1.08	0.81	1.62
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	66.61	21.19	1.51	0.30	0.91	2.72
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	47.18	20.74	0.52	0.00	0.00	1.56
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	66.80	20.10	1.05	0.00	0.42	1.88
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	71.73	25.86	1.95	0.45	1.05	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	48.15	11.69	1.38	1.38	0.69	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	53.81	19.19	0.56	0.19	0.00	1.32
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	62.13	20.99	1.70	0.42	1.27	1.80
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	46.03	9.69	0.48	0.00	0.00	1.94
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	53.59	19.19	0.66	0.00	0.66	1.65
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	67.27	23.54	1.36	0.50	0.87	1.36
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	54.42	15.18	0.74	0.37	0.74	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	59.79	18.28	1.24	0.25	0.49	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	61.32	22.00	2.47	0.41	0.96	1.51
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	47.28	13.83	0.64	0.00	0.00	1.29
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	52.34	25.87	1.52	0.91	1.83	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	60.75	22.53	1.12	0.14	0.56	2.24
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	57.96	13.16	0.00	0.36	0.00	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	65.44	19.39	0.97	0.00	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	65.82	26.30	1.40	0.31	0.47	1.40
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	46.20	12.89	1.07	0.00	0.36	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	60.76	19.60	0.98	0.65	1.31	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	68.74	27.54	1.88	0.47	0.47	0.94
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	68.19	19.80	2.10	0.12	0.25	1.36
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	57.37	21.51	0.00	0.51	0.26	1.02
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	58.48	20.59	0.90	0.00	0.60	1.49
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	43.05	6.80	6.80	4.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	76.71	2.30	4.60	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	66.80	8.16	5.20	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	64.74	3.81	7.19	2.54	0.85	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	74.55	7.74	7.03	4.92	0.00	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	73.78	6.54	4.67	3.74	1.87	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	47.92	8.76	6.70	2.58	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	65.42	8.33	7.14	4.76	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	64.92	10.18	5.43	2.71	0.00	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	54.09	4.07	6.11	0.87	0.29	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	49.97	7.20	2.25	2.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	72.62	8.67	5.15	4.47	0.68	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	53.92	5.14	4.11	2.57	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	43.75	5.29	2.82	2.12	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	51.31	8.66	7.33	4.00	1.33	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	50.94	7.13	3.06	4.08	1.02	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	62.17	6.40	2.67	4.00	1.07	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	52.72	8.88	3.40	2.27	0.38	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	64.42	4.91	1.84	0.61	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	53.82	9.79	2.45	5.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	61.22	6.46	3.54	3.33	0.42	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	51.29	7.85	2.80	1.96	0.28	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	68.00	10.30	3.09	3.09	0.00	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	63.29	7.26	2.61	1.45	0.29	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	47.53	5.38	5.68	2.39	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	55.33	7.75	4.43	4.43	0.00	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	78.83	12.02	5.30	2.83	0.35	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	53.10	7.74	6.64	2.21	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	70.23	5.76	8.06	1.15	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	80.59	6.14	2.69	3.45	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	58.31	6.23	6.23	3.96	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	75.48	9.03	5.74	5.74	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	77.72	9.04	5.42	2.26	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	64.63	7.90	2.87	2.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	70.96	11.20	2.99	2.24	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	71.72	5.95	5.95	1.86	1.11	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	52.12	6.03	2.15	2.15	0.43	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	76.21	10.28	4.28	1.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	66.30	7.66	6.00	1.67	0.33	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	61.54	6.64	4.83	0.60	1.21	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	59.72	7.11	2.84	3.55	0.71	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	62.21	5.50	3.44	1.72	0.34	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	50.45	6.98	2.15	0.54	0.54	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	64.64	7.41	6.73	1.35	0.67	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	75.56	9.26	3.70	2.22	0.37	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	32.56	4.65	4.65	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	68.75	8.46	3.17	2.12	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	66.43	8.80	4.80	1.20	0.40	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	63.24	5.09	7.27	2.91	0.73	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	62.85	13.80	6.13	3.07	0.77	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	66.10	10.36	4.44	2.96	0.49	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	47.05	4.70	2.82	2.82	1.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	65.87	9.05	7.04	3.02	0.50	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	60.38	8.56	4.96	4.51	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	44.75	10.33	6.88	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	78.38	6.68	5.34	2.67	0.45	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	57.48	6.65	4.30	1.56	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	56.74	7.92	5.94	1.98	0.00	2.64
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	66.42	8.82	4.15	4.15	0.00	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	68.26	6.13	6.56	3.50	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	41.37	3.35	4.47	1.68	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	60.50	10.60	3.09	2.21	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	67.89	5.79	5.01	2.31	0.00	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	47.60	6.58	4.05	4.05	0.00	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	56.71	12.02	2.88	5.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	68.78	8.35	5.96	4.37	0.00	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	43.14	9.11	6.08	4.86	1.22	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	58.10	5.53	4.15	1.38	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	59.28	8.74	3.04	3.42	0.38	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	51.64	8.26	2.58	2.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	67.12	5.44	5.44	3.02	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	55.46	7.61	4.12	3.17	0.32	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	53.84	7.46	6.40	4.26	0.00	2.67
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	63.79	5.17	3.45	2.30	1.72	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	62.22	10.28	5.66	2.57	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	62.95	7.07	8.49	4.24	0.71	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	77.75	9.65	7.38	2.84	0.00	2.27
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	77.80	9.98	4.16	2.50	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	76.74	9.40	3.13	3.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	68.90	6.26	4.18	3.76	0.00	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	78.52	11.15	2.32	3.72	0.46	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	52.85	6.02	4.68	5.35	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	73.25	8.02	1.60	2.14	1.07	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	80.42	7.27	2.83	2.42	0.81	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	56.90	7.34	4.59	0.92	3.67	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	76.46	12.45	6.22	4.45	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	80.92	11.40	3.42	2.28	0.57	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	80.52	9.97	2.30	2.30	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	66.21	10.94	5.47	4.38	0.55	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	89.09	12.47	3.56	4.45	0.89	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	83.97	13.26	5.98	5.46	0.00	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	95.49	4.64	2.65	3.32	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	76.91	12.47	12.47	8.31	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	47.63	2.28	0.68	0.00	0.23	0.23
Macrophage - monocyte derived, donor2	11313-117C8	31.56	3.12	1.28	1.10	0.18	0.18
Macrophage - monocyte derived, donor3	11389-118C3	59.25	5.37	0.92	1.05	0.13	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	17.52	1.59	0.00	0.00	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	28.36	2.22	1.43	0.16	0.16	0.00
Mallassez-derived cells, donor3	11930-125I4	27.66	2.78	1.11	0.14	0.28	0.00
Mammary Epithelial Cell, donor1	11273-116H4	20.43	1.99	1.40	0.30	0.00	0.00
Mammary Epithelial Cell, donor2	11350-117G9	16.79	1.45	1.45	0.29	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	34.67	2.74	0.25	0.00	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	20.34	0.68	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	59.69	4.11	2.27	1.19	1.84	0.11
Mast cell, donor2	11565-120D8	82.32	9.81	2.38	0.59	3.57	0.00
Mast cell, donor3	11566-120D9	81.72	11.93	2.93	0.90	2.70	0.23
Mast cell, donor4	11567-120E1	82.97	10.28	1.42	1.24	4.61	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	71.75	8.76	2.33	0.33	1.55	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	46.69	3.50	3.50	0.00	5.25	0.00
Mast cell, expanded, donor5	11939-126A4	75.26	7.34	1.72	0.23	2.52	0.23
Mast cell, expanded, donor8	11941-126A6	76.49	5.69	2.51	0.33	4.85	0.00
Melanocyte - dark, donor1	11502-119F8	142.38	41.39	3.38	0.99	1.49	3.48
Melanocyte - dark, donor2	11582-120F7	47.41	11.42	1.04	0.00	0.69	0.69
Melanocyte - dark, donor3	11663-122F7	110.69	10.29	3.77	1.74	0.22	0.36
Melanocyte - light, donor1	11274-116H5	69.58	8.46	3.29	1.18	3.29	0.71
Melanocyte - light, donor2	11351-117H1	55.96	10.92	4.78	1.36	1.36	0.00
Melanocyte - light, donor3	11423-118G1	40.76	6.94	1.73	0.00	3.47	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	126.82	13.95	3.23	0.62	1.77	1.67
Melanocyte, donor2 (MC+2)	12739-135I3	68.31	7.80	2.42	0.27	1.08	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	67.50	7.77	2.41	0.27	1.61	0.27
Meningeal Cells, donor1	11493-119E8	130.88	27.42	4.34	1.61	0.74	2.85
Meningeal Cells, donor2	11573-120E7	95.51	12.76	1.76	0.44	0.44	0.44
Meningeal Cells, donor3	11654-122E7	124.70	23.39	4.48	2.12	0.24	1.71
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	62.73	7.70	2.85	0.86	0.00	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	30.09	6.14	1.61	0.60	0.10	0.40
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	80.16	10.51	2.63	0.00	3.94	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	61.48	11.77	3.92	0.00	1.31	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	58.84	7.89	1.44	0.00	1.44	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	41.93	5.72	0.85	0.21	0.00	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	46.24	4.52	2.01	1.51	1.51	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	105.04	12.53	3.52	1.54	0.00	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	117.62	5.84	8.77	1.46	0.73	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	106.60	9.82	4.30	0.20	0.82	0.82
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	46.26	4.57	1.52	0.69	0.28	0.83
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	71.37	5.20	2.97	0.00	0.74	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	53.02	6.45	2.24	0.92	0.26	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	33.83	5.04	3.56	0.00	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	37.37	9.34	0.00	0.00	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	57.00	6.40	3.84	0.64	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	76.21	7.09	3.54	2.84	0.35	1.06
Mesenchymal stem cells - hepatic, donor0	11218-116B3	47.85	8.13	0.94	0.63	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	60.23	7.98	2.90	2.18	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	42.96	6.10	1.33	0.00	0.80	0.00
Mesothelial Cells, donor2	12156-128G5	22.52	3.50	1.00	1.00	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	24.86	3.18	0.65	0.22	0.36	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	13.50	0.00	0.00	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	42.61	3.69	1.23	0.25	0.00	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	31.51	4.42	0.00	1.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	0.00	0.00	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	31.30	3.10	1.55	0.31	0.00	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	24.06	3.11	0.62	1.45	0.21	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	45.80	4.00	1.25	0.75	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	16.76	2.79	0.00	0.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	32.92	2.85	1.42	0.61	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	26.93	3.56	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	36.28	1.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	23.94	2.28	0.76	0.38	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	11.84	5.26	0.00	1.32	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	40.75	1.70	0.21	0.64	0.00	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	1.84	2.76	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	26.83	1.79	1.19	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	10.06	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	22.83	3.51	0.25	0.25	0.00	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	15.21	2.14	0.48	0.24	0.00	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	13.82	1.11	0.00	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	25.10	1.84	1.15	0.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	20.19	1.89	0.42	0.21	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	25.07	1.83	1.63	0.61	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	28.96	3.22	1.93	0.00	0.21	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	12.67	1.56	0.22	0.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	24.75	2.41	0.66	0.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	8.11	0.51	0.00	0.51	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	8.28	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	20.66	1.36	0.27	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	17.94	1.76	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	7.63	1.09	1.09	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	31.24	3.84	0.96	0.48	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	22.01	3.20	1.20	0.00	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	6.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	25.03	2.00	0.00	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	18.35	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	17.52	2.63	0.88	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	12.14	0.00	0.00	1.10	0.00	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	16.01	1.92	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	21.07	3.22	1.49	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	6.26	0.00	0.00	0.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	22.10	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	43.42	4.44	1.71	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	8.75	1.75	0.44	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	26.99	4.26	1.07	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	44.61	2.81	1.40	0.84	0.28	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	19.53	1.25	0.00	0.42	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	16.32	4.08	1.17	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	25.94	5.43	1.21	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	25.88	3.76	0.42	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	64.97	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	19.39	3.69	2.77	0.92	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	19.35	1.14	0.57	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	35.24	4.56	1.11	0.00	0.00	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	45.09	7.26	1.55	1.30	0.26	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	20.59	3.43	0.00	0.43	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	24.14	4.45	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	25.35	2.40	1.33	0.80	0.00	1.33
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	25.14	4.79	0.90	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	27.26	2.54	0.42	0.57	0.28	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	40.77	7.64	0.96	0.64	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	30.29	4.42	0.66	0.44	0.22	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	37.16	3.79	0.38	1.14	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	41.76	4.55	1.42	0.57	0.28	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	31.95	3.93	1.72	0.74	0.25	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	28.02	4.56	1.96	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	30.87	6.17	2.65	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	30.56	3.46	0.58	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	19.78	3.71	0.41	1.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	40.80	6.85	0.00	1.49	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	30.14	0.00	3.77	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	21.39	3.56	0.00	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	66.37	4.27	1.64	0.33	0.00	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	36.82	4.21	1.05	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	27.87	2.77	0.79	0.40	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	23.28	1.86	4.66	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	48.82	3.38	2.25	0.38	1.50	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	41.55	4.00	1.07	0.80	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	31.33	2.26	0.90	0.34	0.11	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	42.73	2.21	0.00	0.00	1.47	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	48.37	3.30	1.83	0.00	1.83	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	42.00	4.67	1.56	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	14.96	2.14	1.07	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	42.50	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	55.55	1.01	3.03	1.01	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	24.03	3.79	2.11	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	8.17	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	4.45	0.00	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	1.62	0.00	0.81	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	7.55	3.02	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	0.00	5.71	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	9.79	3.26	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	38.02	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	61.18	8.83	1.29	0.65	0.86	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	43.90	3.66	1.05	0.52	1.05	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	24.03	2.00	0.00	0.00	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	16.69	2.50	0.42	0.00	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	54.00	4.75	1.33	0.76	0.38	0.76
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	20.75	6.38	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	12.24	2.04	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	12.86	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	13.81	5.44	0.00	0.42	0.42	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	26.03	3.95	0.46	0.46	0.46	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	23.24	3.24	0.00	0.27	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	18.50	3.99	1.47	0.42	0.21	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	18.86	2.98	0.50	0.00	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	19.22	2.44	0.00	0.27	0.81	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	25.39	2.49	0.45	0.00	0.23	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	14.86	2.78	0.00	0.16	0.49	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	18.04	3.28	1.09	0.00	0.18	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	16.44	2.12	0.00	0.53	1.06	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	14.41	3.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	29.21	3.61	0.98	0.33	0.33	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	15.77	3.25	0.16	0.16	0.65	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	21.17	4.06	1.06	0.18	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	31.65	4.22	2.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	21.61	2.76	0.92	0.00	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	32.13	1.61	0.64	0.00	0.32	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	35.87	5.17	1.72	0.34	0.69	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	22.76	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	14.04	4.23	0.45	0.89	0.00	0.89
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	28.79	3.81	1.27	0.42	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	21.36	4.75	0.71	0.00	0.47	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	29.62	3.86	1.72	0.00	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	29.99	3.33	0.67	0.00	1.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	13.08	3.16	0.90	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	25.40	3.17	1.98	0.40	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	26.00	1.86	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	30.65	4.54	0.00	0.38	1.51	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	17.27	3.91	0.00	0.33	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	18.74	5.23	0.87	0.00	0.87	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	12.21	2.71	0.45	0.45	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	22.93	3.53	0.00	0.00	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	32.58	6.65	0.66	0.00	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	37.20	3.97	0.99	0.00	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	21.44	3.83	0.38	0.38	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	80.45	10.28	2.12	1.21	1.51	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	22.77	2.65	1.99	0.22	0.22	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	18.30	0.68	0.68	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	0.00	0.00	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	31.70	5.49	1.22	0.00	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	21.72	4.09	0.63	0.31	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	31.48	5.75	0.91	0.00	1.82	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	27.69	6.33	1.58	0.79	0.79	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	23.81	4.53	2.27	2.27	1.13	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	45.52	5.06	0.00	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	35.53	3.23	1.61	0.75	0.12	0.12
Myoblast, donor2	11322-117D8	39.51	4.22	1.34	0.19	0.19	0.38
Myoblast, donor3	11398-118D3	44.73	3.70	3.20	0.34	0.17	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	73.26	2.33	0.29	0.00	0.44	0.00
Natural Killer Cells, donor1	11230-116C6	82.72	4.31	2.77	0.00	0.62	0.00
Natural Killer Cells, donor2	11311-117C6	62.72	4.82	3.62	0.30	0.90	0.00
Natural Killer Cells, donor3	11387-118C1	67.92	2.76	2.58	0.00	0.55	0.00
Neural stem cells, donor1	11275-116H6	24.32	1.81	1.45	0.36	0.36	0.00
Neural stem cells, donor2	11352-117H2	21.18	0.00	1.93	1.93	0.00	1.93
Neurons, donor1	11494-119E9	20.48	0.00	1.14	0.00	0.00	1.14
Neurons, donor2	11574-120E8	23.78	2.86	0.44	0.66	0.00	0.22
Neurons, donor3	11655-122E8	15.62	1.64	0.00	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	2.78	0.00	0.93	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	8.70	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	2.44	0.00	0.00	0.00	1.22	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	53.79	7.24	2.61	0.95	0.00	0.59
Nucleus Pulposus Cell, donor2	11409-118E5	33.86	7.16	2.28	0.00	0.65	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	43.72	6.02	0.80	0.20	0.60	1.00
Olfactory epithelial cells, donor1	11933-125I7	31.11	4.54	0.83	0.28	0.55	0.41
Olfactory epithelial cells, donor2	11934-125I8	37.20	3.62	1.30	0.29	0.43	0.58
Olfactory epithelial cells, donor3	11935-125I9	38.36	4.65	1.70	0.11	0.23	0.34
Olfactory epithelial cells, donor4	11936-126A1	45.78	7.21	1.75	0.58	0.19	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	57.17	3.01	3.01	0.60	0.60	0.60
Osteoblast - differentiated, donor1	11276-116H7	49.35	5.96	2.77	0.85	0.64	0.21
Osteoblast - differentiated, donor2	11353-117H3	21.72	8.00	2.29	2.29	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	52.76	3.72	1.24	0.62	1.86	0.00
Osteoblast, donor1	11277-116H8	54.53	8.01	2.35	1.17	0.00	0.78
Osteoblast, donor2	11354-117H4	69.53	4.21	2.11	0.70	0.00	0.70
Osteoblast, donor3	11426-118G4	66.12	6.58	0.71	0.53	0.18	0.89
Pancreatic stromal cells, donor1	11249-116E7	56.19	5.98	2.02	0.67	1.68	0.59
Pericytes, donor1	11491-119E6	79.00	10.57	3.34	1.56	0.89	0.56
Pericytes, donor2	11571-120E5	79.45	8.60	4.53	1.36	1.13	0.45
Pericytes, donor3	11652-122E5	61.65	9.16	2.85	0.61	0.61	0.20
Perineurial Cells, donor1	11499-119F5	75.05	13.79	2.83	0.79	0.11	0.79
Perineurial Cells, donor2	11579-120F4	46.10	12.24	1.47	1.10	0.28	0.83
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	52.91	3.19	1.27	0.00	0.32	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	36.73	1.47	1.47	0.24	0.73	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	48.66	1.55	2.20	0.13	0.78	0.00
Placental Epithelial Cells, donor1	11278-116H9	93.04	7.65	3.35	1.67	2.87	0.48
Placental Epithelial Cells, donor2	11355-117H5	129.74	7.76	7.76	0.00	0.00	3.33
Placental Epithelial Cells, donor3	11427-118G5	102.09	10.41	3.73	4.52	0.39	0.79
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	53.80	12.34	2.22	0.00	0.95	0.00
Preadipocyte - breast, donor1	11467-119B9	51.02	6.00	2.44	0.00	0.19	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	47.12	7.70	1.70	0.52	0.13	0.13
Preadipocyte - breast, donor2	11328-117E5	49.08	8.78	1.80	1.13	0.68	0.23
Preadipocyte - omental, donor1	11468-119C1	54.77	11.19	3.52	0.96	1.17	0.11
Preadipocyte - omental, donor2	11329-117E6	51.07	8.29	2.18	1.31	0.00	0.44
Preadipocyte - omental, donor3	11403-118D8	52.86	9.02	1.58	1.15	0.43	0.43
Preadipocyte - perirenal, donor1	11469-119C2	54.13	12.80	0.98	0.98	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	35.63	3.38	1.54	0.61	0.31	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	49.58	8.15	1.77	1.24	0.71	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	46.15	4.94	1.19	0.34	0.68	0.00
Preadipocyte - visceral, donor1	11280-116I2	54.12	5.96	1.40	0.65	0.47	0.47
Preadipocyte - visceral, donor2	11357-117H7	28.07	1.84	2.76	0.00	1.38	0.00
Preadipocyte - visceral, donor3	11429-118G7	39.71	3.03	1.04	0.73	0.73	0.63
Prostate Epithelial Cells (polarized), donor1	11253-116F2	43.45	3.47	3.02	2.56	2.41	0.30
Prostate Epithelial Cells, donor2	11331-117E8	13.81	0.95	0.54	0.00	0.14	0.14
Prostate Epithelial Cells, donor3	11404-118D9	7.10	0.37	0.43	0.00	0.55	0.00
Prostate Stromal Cells, donor1	11254-116F3	48.86	6.61	1.82	0.57	0.34	0.80
Prostate Stromal Cells, donor2	11332-117E9	60.96	7.53	2.33	0.18	0.72	0.36
Prostate Stromal Cells, donor3	11405-118E1	42.13	8.45	1.04	0.42	1.56	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	64.24	9.49	2.19	0.00	1.09	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	46.30	5.96	1.73	0.49	0.14	0.21
Renal Epithelial Cells, donor1	11517-119H5	129.85	16.74	6.09	3.04	0.00	1.52
Renal Epithelial Cells, donor2	11597-120H4	70.42	7.11	1.42	0.71	0.71	2.13
Renal Epithelial Cells, donor3	11678-122H4	42.56	5.29	3.07	0.42	0.11	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	100.77	28.60	2.04	0.68	0.68	1.36
Renal Glomerular Endothelial Cells, donor2	11594-120H1	117.38	20.35	3.50	0.81	1.21	2.16
Renal Glomerular Endothelial Cells, donor3	11675-122H1	93.91	17.32	2.66	0.44	0.67	1.11
Renal Glomerular Endothelial Cells, donor4	11783-124B1	160.37	31.28	1.33	0.00	4.66	2.00
Renal Mesangial Cells, donor1	11518-119H6	84.29	8.14	4.62	2.64	1.54	1.32
Renal Mesangial Cells, donor2	11598-120H5	68.34	6.27	3.76	1.25	0.63	0.63
Renal Mesangial Cells, donor3	11679-122H5	63.80	7.77	3.05	1.66	0.28	1.11
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	75.43	5.91	5.10	0.54	0.00	0.81
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	47.65	2.95	2.95	0.42	1.69	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	58.82	7.91	3.09	0.39	0.58	0.77
Retinal Pigment Epithelial Cells, donor0	11215-116A9	75.45	7.26	4.41	0.52	0.00	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	84.14	8.53	5.40	0.85	0.28	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	71.01	2.06	4.12	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	60.97	7.28	8.28	2.51	1.51	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	78.44	11.89	4.68	1.60	1.87	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	28.59	0.89	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	84.76	4.95	2.20	1.65	4.40	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	23.78	1.16	1.16	1.74	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	39.53	2.21	1.56	0.39	0.39	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	51.34	3.18	1.09	0.50	0.40	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	65.47	4.35	1.78	1.00	0.22	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	64.38	3.47	1.36	1.12	0.37	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	61.54	3.15	1.86	0.70	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	55.93	3.24	1.85	0.69	0.69	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	47.92	3.01	0.68	0.41	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	48.86	4.08	1.06	0.61	0.15	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	52.50	4.12	1.25	0.72	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	59.39	5.31	2.73	0.57	0.72	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	56.88	3.97	1.61	1.07	0.21	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	58.19	4.20	0.89	0.66	0.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	42.25	3.82	1.34	0.96	0.38	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	45.46	2.33	1.58	0.93	0.19	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	60.32	5.45	2.07	0.94	0.94	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	50.03	3.45	0.93	0.80	0.27	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	53.73	2.73	1.27	0.78	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	59.01	4.20	1.72	0.57	0.38	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	53.82	3.20	1.82	0.75	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	49.61	3.92	1.96	1.68	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	52.64	2.56	1.37	0.34	0.17	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	48.86	4.56	2.19	0.36	0.55	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	59.35	3.56	0.98	0.49	0.61	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	60.58	3.90	0.81	0.40	0.27	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	64.86	4.72	1.65	1.18	0.71	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	56.75	5.16	1.98	0.20	0.79	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	67.35	5.14	0.47	0.47	1.17	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	57.44	4.15	1.66	1.04	0.41	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	51.32	5.31	2.21	1.11	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	50.34	4.60	0.42	1.04	1.04	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	54.64	2.42	1.35	0.40	0.27	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	47.85	4.09	0.68	0.85	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	59.00	3.28	1.54	0.39	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	62.24	4.64	1.89	0.69	0.86	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	47.73	4.39	0.69	0.69	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	55.82	4.43	1.15	0.66	0.33	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	42.95	4.77	1.19	0.51	0.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	58.74	3.26	1.48	1.33	0.74	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	45.85	2.67	1.07	0.53	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	38.16	1.94	0.69	0.69	0.28	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	49.53	2.14	0.48	0.48	0.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	46.56	3.22	1.21	0.81	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	43.23	1.98	2.26	0.38	1.13	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	43.67	2.45	2.79	0.35	2.45	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	24.18	3.32	1.51	0.30	0.91	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	59.60	2.08	2.08	1.10	2.69	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	32.02	2.33	1.89	0.44	0.15	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	41.98	3.04	1.22	0.61	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	54.85	2.11	1.81	0.00	2.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	94.09	4.52	2.94	1.36	8.37	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	59.31	3.00	0.90	0.00	2.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	79.58	4.01	2.13	0.94	19.13	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	68.30	2.77	1.71	0.43	7.47	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	54.09	4.21	0.00	0.00	0.60	0.00
Schwann Cells, donor1	11498-119F4	76.17	11.28	3.39	2.07	0.94	1.32
Schwann Cells, donor2	11578-120F3	37.43	10.21	3.40	0.00	0.00	3.40
Schwann Cells, donor3	11659-122F3	67.48	12.05	2.19	0.22	0.00	1.10
Sebocyte, donor1	11220-116B5	21.36	1.10	1.64	0.55	0.00	0.00
Sebocyte, donor2	11301-117B5	11.03	1.84	0.46	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	45.14	4.12	0.82	0.62	0.41	0.00
Sertoli Cells, donor1	11255-116F4	57.98	11.60	3.31	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	28.24	5.65	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	55.25	7.30	2.38	1.14	2.46	0.35
Skeletal Muscle Cells, donor2	11358-117H8	32.53	5.78	2.89	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	82.77	10.87	1.67	1.67	0.84	1.67
Skeletal Muscle Cells, donor4	11451-119A2	36.29	7.23	0.94	0.31	0.16	0.79
Skeletal Muscle Cells, donor5	11455-119A6	30.03	5.20	2.68	0.00	0.30	0.45
Skeletal Muscle Cells, donor6	11459-119B1	54.94	5.85	1.69	0.46	0.77	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	32.13	4.91	1.26	0.63	0.38	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	31.68	4.28	2.28	0.43	0.29	0.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	51.69	7.64	2.38	0.69	0.00	0.79
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	63.86	9.69	6.15	1.94	1.26	0.84
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	47.04	4.34	0.72	0.00	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	28.90	5.64	1.24	0.55	0.28	0.55
Skin - palm, donor1	10286-104F7	53.72	18.80	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	9.66	1.44	0.58	0.00	0.14	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	9.00	3.27	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	10.00	0.78	0.39	0.26	0.52	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	8.90	0.14	0.14	0.28	0.28	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	6.05	0.98	0.56	0.00	0.00	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	14.38	1.27	0.42	0.21	0.00	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	4.95	0.67	0.22	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	6.48	1.23	0.62	0.00	0.00	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	72.70	8.45	2.67	0.00	0.89	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	32.33	5.29	4.11	0.59	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	59.00	10.83	2.43	1.10	0.22	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	38.59	7.48	3.54	1.18	0.00	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	28.58	6.18	1.55	0.77	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	27.02	3.00	1.00	1.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	46.18	7.72	2.13	0.00	0.13	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	45.88	8.64	1.11	0.44	0.22	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	29.58	4.10	0.51	0.77	0.38	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	51.12	10.09	1.63	0.98	0.33	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	47.55	4.73	0.89	0.59	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	32.74	4.13	1.99	0.28	0.28	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	60.35	5.53	1.63	0.81	0.16	0.98
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	39.58	2.13	2.74	0.30	0.00	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	48.74	9.09	3.03	0.25	0.25	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	67.33	0.00	6.12	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	49.11	8.11	2.38	0.95	0.48	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	29.35	2.21	1.03	0.29	0.44	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	26.69	3.01	1.72	0.00	0.00	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	38.83	4.72	0.94	0.42	0.31	0.84
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	48.88	5.41	2.47	0.77	0.15	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	28.02	6.47	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	40.35	6.28	1.79	0.90	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	68.28	8.53	2.73	2.05	0.00	1.02
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	34.32	5.58	1.57	0.86	0.24	0.63
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	23.65	2.72	0.40	0.30	1.81	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	67.81	7.74	2.73	0.68	1.37	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	47.10	9.66	3.02	0.60	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	91.93	10.60	3.44	0.79	0.00	1.32
Smooth Muscle Cells - Prostate, donor1	11257-116F6	41.41	6.13	2.80	1.20	1.33	0.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	31.30	6.89	1.00	0.63	1.13	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	42.87	6.09	1.78	1.01	1.52	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	49.60	6.18	0.90	0.75	0.45	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	31.51	8.25	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	100.79	14.21	2.58	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	52.55	11.63	2.33	3.26	0.93	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	50.99	4.04	2.52	0.50	1.01	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	34.16	6.89	0.94	0.00	1.57	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	33.63	3.83	0.59	0.88	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	63.06	8.00	2.67	1.42	0.00	0.83
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	27.56	5.61	0.00	0.00	0.00	1.40
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	31.66	6.19	2.01	0.58	0.43	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	55.33	9.69	1.27	0.25	0.25	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	46.82	4.51	1.50	0.38	0.00	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	41.22	4.75	0.98	0.98	0.14	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	44.91	7.96	1.42	0.67	0.00	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	38.09	3.81	1.43	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	31.07	4.65	1.22	0.49	0.73	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	35.79	7.29	1.33	0.88	1.10	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	33.65	2.63	1.46	0.29	0.00	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	44.70	6.80	2.14	0.39	0.58	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	29.88	2.64	1.59	0.00	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	58.40	7.81	1.49	0.74	2.23	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	33.78	5.39	1.80	0.00	0.72	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	20.72	3.12	1.99	0.28	0.00	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	59.47	8.27	0.79	0.00	0.79	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	29.46	7.36	1.27	0.51	0.51	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	19.97	2.80	2.00	0.00	2.80	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	30.51	3.34	1.67	1.25	2.09	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	42.17	5.04	0.46	1.83	0.92	0.00
Synoviocyte, donor1	11291-117A4	55.55	9.59	2.19	0.34	1.01	0.34
Synoviocyte, donor2	11368-117I9	67.22	11.06	1.84	0.34	2.01	0.34
Synoviocyte, donor3	11440-118H9	69.93	8.27	1.34	1.34	1.56	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	107.91	11.43	3.93	1.79	0.00	2.14
Trabecular Meshwork Cells, donor2	11612-122A1	45.59	5.95	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	79.65	9.49	3.24	1.85	0.69	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	10.11	1.15	0.72	0.22	0.00	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	23.19	2.71	1.16	0.00	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	16.61	1.72	0.57	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	79.72	11.20	5.04	1.35	3.20	0.74
Urethra, donor2	10319-105A4	57.55	23.38	1.80	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	15.67	1.59	1.06	1.06	0.00	0.00
Urothelial Cells, donor2	11600-120H7	19.63	2.00	0.00	0.40	0.40	0.00
Urothelial Cells, donor3	11681-122H7	23.15	0.92	1.15	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	17.39	1.56	0.00	0.22	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	54.28	2.67	5.34	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	70.05	1.43	1.43	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	37.65	1.37	1.37	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	56.82	2.07	2.07	0.34	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	36.60	2.32	2.32	0.58	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	59.35	1.04	0.00	0.00	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	44.97	4.59	3.67	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	53.86	1.83	1.83	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	28.87	2.84	0.99	0.37	0.25	0.00
Wilms' tumor cell line:HFWT	10597-108E3	22.00	6.16	0.88	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	31.28	2.79	2.23	0.84	0.00	0.56
achilles tendon, donor2	10292-104G4	26.86	8.27	4.13	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	55.84	1.27	1.53	0.51	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	52.24	3.02	4.88	0.93	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	90.81	3.21	4.87	0.36	0.36	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	127.89	6.53	5.44	1.63	0.54	0.82
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	126.49	6.75	2.25	0.00	0.84	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	68.73	5.92	2.54	0.63	0.21	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	52.26	2.45	2.18	0.27	0.00	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	66.10	2.64	2.20	0.44	0.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	107.81	6.94	3.27	1.23	0.82	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	56.69	3.11	2.72	1.16	0.78	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	106.72	4.42	3.31	1.10	0.92	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	62.41	7.80	7.80	0.00	0.00	7.80
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	117.59	4.88	3.95	0.93	0.70	1.16
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	112.10	3.37	3.11	0.52	0.52	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	85.63	7.31	1.75	0.58	0.29	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	19.52	2.79	2.79	1.39	0.00	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	79.37	4.52	2.47	0.82	0.41	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	42.05	2.76	0.31	0.00	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	78.09	5.55	2.13	1.28	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	85.53	8.49	1.21	1.21	0.00	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	94.60	7.70	3.61	0.96	0.00	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	88.87	3.34	2.00	0.67	0.89	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	49.36	4.00	1.33	0.67	0.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	22.30	9.29	1.86	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	62.53	9.42	3.01	0.38	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	67.16	6.11	1.74	1.31	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	18.74	15.00	1.87	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	34.85	0.94	0.94	0.24	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	94.00	16.91	6.20	1.71	4.65	1.40
adipose, donor1	10184-103D4	39.29	4.69	0.59	0.59	4.10	0.59
adipose, donor2	10185-103D5	8.92	0.81	0.00	0.81	4.06	0.00
adipose, donor3	10186-103D6	20.42	1.36	1.09	0.00	5.17	0.00
adipose, donor4	10187-103D7	20.80	0.00	0.00	0.00	1.73	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	77.02	13.57	3.16	1.42	0.47	0.32
adrenal gland, adult, pool1	10081-102A9	69.12	3.64	7.28	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	68.57	3.20	2.53	0.13	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	72.17	7.50	1.79	1.07	2.14	0.00
amniotic membrane cells, donor1	12235-129G3	88.10	4.87	5.10	0.93	0.00	0.46
amniotic membrane cells, donor2	12236-129G4	79.12	4.73	3.72	5.07	1.01	1.35
amniotic membrane cells, donor3	12237-129G5	99.28	4.42	2.95	2.95	0.00	0.00
amygdala - adult, donor10196	10167-103B5	16.60	2.37	1.19	0.00	1.19	0.00
amygdala, adult, donor10252	10151-102I7	29.20	2.84	1.82	0.41	0.00	0.00
amygdala, newborn, donor10223	10360-105E9	13.23	3.55	1.94	0.00	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	25.47	4.58	3.44	0.51	1.15	0.76
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	123.99	4.19	2.43	0.00	0.88	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	17.04	1.34	0.33	0.33	0.00	0.00
aorta, adult, pool1	10052-101G7	101.79	16.48	4.31	1.37	0.78	1.57
appendix, adult	10189-103D9	75.68	16.30	1.94	0.78	1.16	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	33.36	3.44	2.41	0.34	0.69	0.69
artery, adult	10190-103E1	67.93	20.38	8.15	0.00	4.08	2.72
astrocytoma cell line:TM-31	10425-106D2	75.91	6.52	2.61	0.43	0.29	0.14
b cell line:RPMI1788	10427-106D4	31.38	3.27	1.04	0.15	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	54.38	4.44	0.55	0.28	0.00	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	47.93	4.27	2.58	0.79	0.40	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	12.39	1.34	1.51	0.33	0.50	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	59.28	6.15	4.47	0.00	0.56	0.00
bladder, adult, pool1	10011-101C2	83.33	18.03	4.13	1.63	1.96	0.76
blood, adult, pool1	10053-101G8	57.58	2.21	2.21	0.00	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	25.69	0.86	1.71	0.00	0.00	0.00
bone marrow, adult	10192-103E3	74.91	12.15	1.35	0.00	1.35	0.00
brain, adult, donor1	10084-102B3	43.05	2.05	1.03	1.03	2.05	0.00
brain, adult, pool1	10012-101C3	39.87	4.90	1.45	0.45	0.45	0.33
brain, fetal, pool1	10085-102B4	24.04	5.34	2.67	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	32.38	4.96	0.66	1.65	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	57.17	3.12	4.12	1.12	0.00	0.12
breast, adult, donor1	10080-102A8	94.07	13.26	3.79	0.00	6.31	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	57.68	3.94	2.79	2.16	0.25	0.76
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	35.87	3.40	4.02	0.62	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	127.77	19.80	11.05	5.53	1.15	1.38
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	0.00	0.00	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	15.99	0.00	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	39.38	4.59	2.19	0.44	0.00	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	8.56	0.95	0.32	0.32	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	20.23	1.86	1.06	0.53	0.00	0.27
caudate nucleus - adult, donor10196	10177-103C6	20.72	1.15	1.15	0.00	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	33.30	3.51	0.67	0.33	0.00	0.00
caudate nucleus, adult, donor10258	10379-105H1	36.68	2.29	2.29	1.53	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	11.35	1.10	0.73	0.37	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	32.05	0.00	2.91	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	59.36	5.76	2.78	0.43	0.00	0.21
cerebellum, adult, pool1	10083-102B2	44.50	4.48	0.69	1.03	0.34	0.00
cerebellum, newborn, donor10223	10357-105E6	28.23	1.66	1.66	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	39.33	9.08	0.25	0.50	0.00	0.50
cerebrospinal fluid, donor2	10294-104G6	23.39	0.00	2.19	0.00	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	32.21	2.30	1.29	0.00	0.14	0.14
cervical cancer cell line:ME-180	10553-107I4	23.53	1.16	2.65	0.50	0.33	0.00
cervix, adult, pool1	10013-101C4	120.63	26.46	5.67	3.88	3.36	1.89
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	43.19	7.11	6.13	1.95	0.28	0.84
chondrosarcoma cell line:SW 1353	10700-109G7	20.90	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	37.16	4.47	1.86	1.49	2.61	0.12
choriocarcinoma cell line:SCH	10785-110H2	13.55	1.36	1.60	0.62	0.00	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	25.38	2.85	0.71	0.24	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	61.26	7.12	3.13	1.42	0.57	1.14
chorionic membrane cells, donor2	12239-129G7	52.30	5.47	2.88	0.80	1.09	0.30
chorionic membrane cells, donor3	12240-129G8	63.74	5.49	3.30	1.65	0.55	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	112.09	7.07	4.04	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	97.59	5.38	1.34	0.19	0.19	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	59.34	6.55	1.27	0.84	0.21	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	30.56	3.34	0.00	0.51	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	30.96	2.90	0.73	0.24	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	25.04	4.07	0.41	0.20	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	58.89	5.01	0.88	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	122.49	6.78	4.43	0.52	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	55.55	3.89	1.37	1.14	0.46	0.00
clear cell carcinoma cell line:TEN	10636-108I6	51.36	4.68	2.78	0.69	0.35	0.17
colon carcinoma cell line:CACO-2	10513-107D9	78.89	3.29	6.41	1.46	0.37	0.37
colon carcinoma cell line:COLO-320	10420-106C6	58.91	6.84	3.04	1.14	0.00	0.00
colon, adult, donor1	10082-102B1	47.60	8.33	2.38	2.38	1.19	0.00
colon, adult, pool1	10014-101C5	52.99	9.52	2.35	1.53	1.29	0.59
colon, fetal, donor1	10070-101I7	32.75	7.42	0.62	0.00	3.09	0.62
common myeloid progenitor CMP, donor1	12130-128D6	9.17	4.58	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	27.62	0.85	2.12	0.42	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	53.88	2.11	2.26	0.15	0.30	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	59.37	2.68	2.68	0.00	0.14	0.00
corpus callosum, adult, pool1	10042-101F6	66.45	7.85	2.54	1.66	0.55	0.11
cruciate ligament, donor2	10295-104G7	42.95	10.54	3.24	0.81	0.81	0.81
diaphragm, fetal, donor1	10069-101I6	50.56	14.45	3.21	0.00	1.61	0.80
diencephalon, adult	10193-103E4	24.96	4.56	1.44	0.72	0.72	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	54.19	1.61	0.46	0.23	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	20.52	2.56	0.77	0.77	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	27.68	2.41	1.69	0.00	0.00	0.00
ductus deferens, adult	10196-103E7	45.85	10.47	3.99	1.99	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	33.13	10.08	1.44	1.44	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	43.40	13.24	1.47	1.47	1.47	0.00
dura mater, adult, donor1	10041-101F5	95.39	20.98	4.38	2.31	0.25	2.73
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	44.64	5.11	6.44	2.44	1.55	0.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	54.31	7.16	7.88	2.29	0.86	0.72
embryonic pancreas cell line:1B2C6	10604-108F1	20.35	3.70	1.23	0.62	0.00	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	26.03	5.15	2.12	0.30	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	18.52	2.47	0.93	0.00	0.00	0.31
embryonic pancreas cell line:2C6	10603-108E9	18.39	3.94	0.00	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	9.72	0.67	0.67	0.00	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	37.70	4.35	3.08	1.45	0.36	0.91
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	31.84	5.15	2.89	0.32	1.13	0.32
epidermoid carcinoma cell line:A431	10426-106D3	40.13	2.45	2.22	1.67	0.22	0.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	80.40	5.39	4.95	2.42	0.33	0.33
epididymis, adult	10197-103E8	71.58	12.77	3.77	0.84	6.07	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	40.27	6.03	1.42	0.71	0.18	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	38.93	2.75	0.39	0.00	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	96.32	9.17	3.15	0.79	0.39	0.52
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	89.56	7.09	3.74	1.38	0.20	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	98.59	8.07	3.81	1.12	0.11	0.34
esophagus, adult, pool1	10015-101C6	89.19	10.51	7.33	1.27	3.29	0.96
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	38.95	8.77	1.50	0.88	0.50	0.25
eye - muscle inferior rectus, donor1	10272-104E2	77.27	12.07	4.83	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	44.19	10.52	0.00	0.00	2.10	0.00
eye - muscle medial, donor2	10299-104H2	35.72	11.91	1.49	1.49	0.00	1.49
eye - muscle superior, donor2	10297-104G9	52.74	17.20	2.29	1.15	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	14.57	0.00	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	69.15	10.68	2.29	1.27	0.25	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	61.16	4.74	2.18	0.90	0.90	0.90
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	44.40	8.78	4.27	1.19	0.00	0.24
frontal lobe, adult, pool1	10040-101F4	39.69	6.00	1.41	0.66	0.00	0.56
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	50.44	2.70	6.31	2.70	0.90	1.20
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	31.55	5.03	1.37	0.64	0.18	0.18
gall bladder, adult	10198-103E9	82.57	17.38	3.38	0.24	1.69	0.97
gamma delta positive T cells, donor1	11937-126A2	130.99	7.52	3.76	0.00	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	123.63	2.24	7.47	0.37	0.75	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	29.15	4.65	2.32	1.69	0.21	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	31.53	3.67	0.97	0.19	0.00	0.39
gastric cancer cell line:AZ521	10549-107H9	30.33	3.44	1.48	0.33	0.00	0.49
gastric cancer cell line:GSS	10560-108A2	64.98	7.32	5.49	0.92	1.83	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	31.07	5.48	3.20	1.83	0.46	0.23
giant cell carcinoma cell line:LU65	10487-107B1	33.50	3.44	1.61	0.11	0.11	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	19.87	5.88	2.80	0.28	0.14	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	25.94	1.25	1.25	0.00	1.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	37.68	6.23	1.48	0.74	0.00	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	38.48	4.92	1.40	0.28	0.00	0.56
glioblastoma cell line:T98G	10485-107A8	67.66	7.28	2.65	1.21	0.00	0.66
glioma cell line:GI-1	10413-106B8	79.08	4.98	2.93	0.59	0.88	0.59
globus pallidus - adult, donor10196	10175-103C4	13.12	4.37	1.46	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	53.94	6.83	2.93	0.24	0.24	0.24
globus pallidus, adult, donor10258	10367-105F7	38.34	6.85	2.74	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	19.19	3.20	0.53	0.00	2.13	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	22.02	2.45	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	99.31	10.45	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	32.00	4.48	0.64	0.64	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	15.61	2.75	0.46	0.00	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	13.72	4.57	0.46	0.46	0.00	0.46
hIPS +CCl2, biol_rep3	14385-156C2	10.95	4.51	0.00	0.64	0.64	0.00
hIPS, biol_rep1	14380-156B6	12.94	1.44	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	8.92	1.37	0.00	0.69	0.69	0.00
hIPS, biol_rep3	14382-156B8	32.00	7.72	0.00	0.00	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	44.83	1.72	2.01	0.00	0.57	0.00
heart - mitral valve, adult	10205-103F7	60.99	20.93	3.29	0.60	0.30	0.30
heart - pulmonic valve, adult	10206-103F8	57.52	18.04	4.18	2.35	0.78	0.26
heart - tricuspid valve, adult	10207-103F9	55.79	18.32	2.50	0.00	2.50	2.50
heart, adult, diseased post-infarction, donor1	10050-101G5	78.97	14.90	2.45	2.04	1.63	0.41
heart, adult, diseased, donor1	10051-101G6	96.24	19.16	4.68	0.85	0.85	0.00
heart, adult, pool1	10016-101C7	39.33	10.58	3.68	0.92	0.00	0.00
heart, fetal, pool1	10046-101G1	69.82	18.38	3.70	1.64	0.00	0.92
hepatic mesenchymal tumor cell line:LI90	10778-110G4	29.62	4.32	0.31	0.31	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	15.46	4.76	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	17.24	4.20	4.97	2.32	0.11	0.77
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	21.36	4.37	4.49	3.28	0.24	1.09
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	20.41	3.44	3.84	2.32	0.10	0.61
hepatoma cell line:Li-7	10484-107A7	33.92	2.11	2.00	0.78	0.11	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	92.46	3.52	1.91	0.70	0.10	0.10
hippocampus - adult, donor10196	10169-103B7	17.98	4.73	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	42.45	5.10	1.43	0.61	0.20	0.00
hippocampus, adult, donor10258	10374-105G5	15.44	5.48	1.99	0.50	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	11.63	2.11	0.35	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	34.18	2.44	6.10	0.00	1.22	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	18.65	1.18	1.57	0.79	1.37	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	17.26	3.05	1.27	1.02	0.76	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	23.12	3.38	2.26	0.00	2.82	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	26.08	3.10	1.55	0.00	3.87	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	28.09	1.90	1.14	0.76	4.56	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	22.48	2.63	1.17	0.29	4.96	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	18.31	3.45	0.00	0.43	4.09	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	19.19	5.42	0.83	0.00	2.09	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	37.65	2.84	1.18	1.18	1.89	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	38.73	5.30	0.96	0.80	4.66	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	29.63	4.71	2.69	0.00	1.35	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	15.18	2.03	1.72	0.31	0.78	0.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	12.28	3.93	2.46	0.49	1.47	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	22.69	0.87	1.75	0.00	1.75	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	28.83	3.44	0.95	0.00	9.55	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	27.91	2.18	1.31	1.31	2.18	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	21.99	4.00	1.50	1.50	4.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	10.55	0.94	0.94	0.00	2.64	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	7.28	2.73	0.91	0.00	2.73	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	12.53	1.57	0.94	0.31	1.88	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	37.56	5.23	1.96	0.16	5.06	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	40.64	6.10	2.03	0.58	5.52	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	28.40	7.17	1.49	0.90	6.58	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	21.06	2.22	1.85	0.74	1.48	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	19.11	0.86	1.14	0.29	1.71	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	20.01	4.90	4.08	0.82	2.45	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	30.28	4.58	1.06	1.06	5.99	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	24.07	4.12	1.58	0.32	8.24	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	35.71	5.45	1.21	1.51	3.33	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	17.07	5.17	1.55	0.52	2.59	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	15.94	0.66	1.33	0.66	0.66	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	20.01	1.54	2.57	0.00	0.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	36.81	8.69	1.28	0.51	5.88	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	36.35	4.54	2.27	0.76	5.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	41.00	8.07	2.69	0.34	5.71	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	19.56	3.86	1.93	0.97	0.72	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	18.72	2.67	1.34	2.23	0.89	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	20.98	2.44	2.44	0.49	1.95	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	27.20	2.75	1.22	0.61	5.81	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	48.80	6.51	6.51	3.25	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	46.99	2.98	5.30	0.33	9.27	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	23.53	4.38	0.00	0.00	3.28	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	12.30	2.90	1.09	0.00	2.53	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	12.46	1.42	0.71	0.36	2.14	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	20.29	2.39	2.39	0.00	4.77	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	37.65	5.96	1.22	0.68	6.23	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	25.32	4.58	1.35	0.27	3.77	0.27
immature langerhans cells, donor1	11904-125F5	6.54	0.97	0.48	0.48	0.00	0.00
immature langerhans cells, donor2	11905-125F6	13.47	2.38	0.79	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	35.77	5.39	2.84	0.38	0.19	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	31.86	1.95	0.65	0.33	0.33	0.33
kidney, adult, pool1	10017-101C8	70.29	12.32	4.71	1.70	0.60	1.30
kidney, fetal, pool1	10045-101F9	67.91	16.41	4.88	3.68	0.28	1.41
large cell lung carcinoma cell line:IA-LM	10509-107D5	23.29	5.25	1.28	0.28	0.28	0.71
large cell lung carcinoma cell line:NCI-H460	10839-111E2	20.74	2.49	0.28	0.14	0.00	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	10.46	1.10	0.37	0.00	0.18	0.00
left atrium, adult, donor1	10079-102A7	59.39	13.62	2.72	0.00	3.81	0.54
left ventricle, adult, donor1	10078-102A6	68.77	17.70	1.52	0.00	4.55	0.00
leiomyoblastoma cell line:G-402	10721-110A1	36.39	3.56	1.37	1.09	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	22.99	2.16	0.72	0.00	1.44	0.00
leiomyoma cell line:15242A	10570-108B3	30.43	6.52	2.17	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	35.69	4.61	0.49	0.00	1.21	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	31.75	6.35	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	11.50	4.18	1.05	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	58.32	5.90	1.77	0.47	0.47	0.00
liposarcoma cell line:KMLS-1	10782-110G8	37.02	7.81	1.09	0.16	0.31	0.00
liposarcoma cell line:SW 872	10726-110A6	54.58	4.87	1.22	0.49	0.24	0.00
liver, adult, pool1	10018-101C9	66.45	7.29	4.70	1.46	5.02	0.49
liver, fetal, pool1	10086-102B5	42.33	3.76	0.00	0.00	1.88	0.00
locus coeruleus - adult, donor10196	10182-103D2	16.04	3.21	1.17	0.29	0.15	0.00
locus coeruleus, adult, donor10252	10165-103B3	35.80	4.98	2.40	0.18	0.18	0.18
locus coeruleus, adult, donor10258	10375-105G6	24.26	3.67	1.13	0.85	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	44.59	5.47	2.52	1.26	1.26	0.00
lung adenocarcinoma cell line:A549	10499-107C4	10.66	1.25	0.14	0.14	0.00	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	19.99	0.69	1.38	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	47.32	4.75	1.71	1.05	0.53	0.26
lung, adult, pool1	10019-101D1	86.11	13.23	3.90	1.65	3.07	0.71
lung, fetal, donor1	10068-101I5	90.47	15.13	7.99	2.00	0.86	2.00
lung, right lower lobe, adult, donor1	10075-102A3	82.94	15.12	4.58	1.83	13.29	2.29
lymph node, adult, donor1	10077-102A5	55.38	8.99	1.89	0.00	5.21	0.47
lymphangiectasia cell line:DS-1	10727-110A7	96.88	2.63	0.88	0.00	0.66	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	76.07	4.53	1.51	0.00	0.30	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	43.32	5.95	3.40	0.00	1.70	0.00
mature adipocyte, donor1	12231-129F8	51.06	13.32	3.55	3.55	0.00	0.44
mature adipocyte, donor2	12232-129F9	62.67	12.45	3.94	1.45	0.83	0.83
mature adipocyte, donor3	12233-129G1	47.89	9.25	4.27	1.42	0.00	0.24
mature adipocyte, donor4	12234-129G2	55.54	10.27	5.00	0.79	0.26	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	23.35	3.81	2.14	0.48	0.00	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	18.05	1.13	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	32.55	5.33	2.02	0.37	0.55	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	18.11	3.81	1.27	0.00	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	18.77	3.84	0.85	1.28	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	27.51	3.71	1.52	0.00	0.00	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	36.50	6.15	1.27	0.42	0.21	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	17.34	7.71	5.78	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	15.79	0.72	0.00	0.00	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	33.10	3.24	2.60	1.30	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	49.69	7.43	3.10	0.62	0.46	0.46
medulla oblongata, adult, pool1	10038-101F2	48.08	8.57	2.37	0.82	0.08	0.49
medulla oblongata, newborn, donor10223	10361-105F1	35.41	4.86	1.04	0.00	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	33.43	3.54	7.53	0.44	0.44	1.33
medulloblastoma cell line:ONS-76	10759-110E3	27.39	3.18	0.24	0.49	0.37	0.00
melanoma cell line:COLO 679	10514-107E1	48.87	5.03	1.72	0.29	2.01	0.14
melanoma cell line:G-361	10465-106H6	41.53	5.70	2.44	0.54	5.97	0.54
meningioma cell line:HKBMM	10691-109F7	38.53	3.26	1.45	0.18	0.18	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	43.18	3.52	3.52	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	35.51	1.30	0.78	0.26	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	42.81	4.14	1.38	0.92	0.15	0.77
mesenchymal precursor cell - adipose, donor2	11748-123G2	21.09	3.27	0.73	0.00	0.00	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	40.58	4.56	1.66	0.41	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	37.79	1.55	0.70	0.28	0.14	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	36.01	2.31	0.96	0.58	0.00	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	29.15	2.08	2.08	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	24.37	2.92	0.69	0.34	0.86	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	32.89	4.14	1.04	0.46	0.46	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	32.63	4.24	0.40	0.80	0.27	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	43.08	4.46	1.49	0.68	0.41	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	39.55	2.70	1.99	0.14	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	21.41	4.61	2.31	0.00	0.66	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	24.91	2.35	0.69	0.83	0.00	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	28.97	4.54	1.75	0.00	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	31.65	4.08	0.82	0.41	0.20	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	19.05	4.31	1.44	0.00	1.08	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	30.72	3.62	0.52	0.31	0.00	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	21.66	3.42	0.91	0.46	0.23	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	49.09	3.78	1.26	0.42	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	30.78	3.29	1.05	0.75	0.15	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	32.82	2.71	1.58	0.26	0.09	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	43.44	2.95	1.84	0.37	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	32.05	4.58	1.43	0.00	0.57	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	91.78	7.16	2.53	1.68	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	32.88	3.65	0.91	0.46	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	36.32	6.91	1.28	0.77	0.51	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	37.69	5.76	0.79	0.26	0.00	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	31.73	6.47	1.54	0.62	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	27.77	4.00	0.94	0.71	0.94	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	29.11	7.78	2.03	0.68	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	31.04	5.50	0.39	1.96	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	30.58	7.88	1.39	0.00	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	38.07	5.48	2.02	0.58	0.58	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	33.24	6.92	1.56	0.67	0.22	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	29.80	6.73	0.72	0.96	0.24	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	19.80	6.60	0.73	1.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	34.91	6.71	1.34	0.00	1.01	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	32.75	5.32	0.82	1.23	1.23	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	38.66	3.87	1.29	0.43	0.00	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	27.34	5.47	0.00	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	56.81	10.33	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	33.78	6.50	0.32	0.32	0.65	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	30.55	5.82	1.45	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	29.85	4.26	0.53	0.00	1.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	26.17	1.64	0.82	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	32.65	8.94	3.11	0.39	0.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	25.18	8.39	2.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	24.84	5.96	0.99	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	30.83	5.93	1.78	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	18.28	8.53	1.22	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	32.30	3.80	1.90	0.00	0.63	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	40.70	6.55	1.72	0.34	1.38	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	30.09	4.30	2.15	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	35.93	0.00	3.99	7.98	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	20.66	3.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	38.30	3.67	1.63	0.41	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	42.90	6.36	1.59	1.59	1.59	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	42.45	4.72	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	38.34	5.30	1.25	0.62	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	48.12	5.35	2.67	0.00	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	39.03	9.46	2.37	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	30.82	10.27	5.14	0.00	2.57	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	46.12	11.01	3.44	2.07	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	35.13	8.41	3.46	0.00	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	41.50	7.85	1.12	1.12	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	31.80	5.72	3.82	0.64	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	36.27	8.06	2.01	0.00	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	30.53	10.90	2.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	36.74	3.80	1.27	1.27	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	32.77	3.03	0.61	0.61	1.82	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	27.11	4.52	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	28.83	4.12	4.12	0.00	1.65	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	43.46	3.17	2.18	0.40	0.99	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	48.03	6.49	2.27	0.00	1.30	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	61.12	5.09	2.04	1.02	3.06	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	13.93	4.64	1.55	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	40.40	6.14	2.83	0.94	0.47	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	29.19	2.55	2.09	1.39	0.00	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	29.92	8.55	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	32.37	2.77	1.64	0.21	0.41	0.21
mesothelioma cell line:Mero-25	10850-111F4	34.27	3.18	1.59	0.45	0.23	0.23
mesothelioma cell line:Mero-41	10851-111F5	55.25	6.85	1.96	0.98	0.98	0.24
mesothelioma cell line:Mero-48a	10852-111F6	49.38	4.65	1.77	0.00	0.22	0.44
mesothelioma cell line:Mero-82	10853-111F7	68.33	7.62	2.89	1.05	1.05	0.00
mesothelioma cell line:Mero-83	10854-111F8	38.47	5.45	0.68	0.34	0.85	0.85
mesothelioma cell line:Mero-84	10855-111F9	54.35	5.06	1.77	0.76	0.76	0.25
mesothelioma cell line:Mero-95	10856-111G1	48.24	5.59	1.66	0.62	1.24	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	104.36	10.44	4.47	0.83	1.49	0.17
mesothelioma cell line:NCI-H226	10846-111E9	87.42	9.05	1.63	0.18	1.27	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	90.88	7.17	3.59	0.85	0.68	0.68
mesothelioma cell line:NCI-H28	10845-111E8	35.63	3.82	2.29	1.27	0.25	0.25
mesothelioma cell line:No36	10857-111G2	48.93	8.81	8.16	0.00	1.30	0.98
mesothelioma cell line:ONE58	10858-111G3	37.93	5.96	2.44	0.00	0.27	0.00
migratory langerhans cells, donor1	11901-125F2	59.88	8.25	2.69	0.38	0.58	0.00
migratory langerhans cells, donor2	11902-125F3	50.68	9.53	3.30	0.12	0.24	0.00
migratory langerhans cells, donor3	11903-125F4	40.92	4.49	2.69	0.18	0.36	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	39.18	3.59	1.96	0.33	0.98	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	55.53	5.51	1.06	0.64	0.21	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	13.13	1.38	0.69	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	55.95	2.85	1.90	0.57	1.14	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	102.37	4.80	4.07	2.03	0.37	0.18
myeloma cell line:PCM6	10474-106I6	137.58	9.69	3.76	0.00	0.99	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	34.50	2.54	0.51	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	129.65	8.83	3.33	0.78	1.37	1.18
nasal epithelial cells, donor1, tech_rep1	12226-129F3	7.58	0.78	0.45	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	7.35	0.51	0.44	0.00	0.00	0.00
nasal epithelial cells, donor2	12227-129F4	21.53	1.66	0.00	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	10.81	0.92	0.46	0.23	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	28.62	3.74	1.31	0.94	0.00	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	37.54	6.12	0.42	0.00	0.00	0.42
neuroblastoma cell line:NH-12	10555-107I6	25.34	2.42	1.86	0.19	0.00	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	36.77	3.56	0.47	0.71	0.24	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	39.28	7.92	0.79	0.48	0.48	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	39.45	3.82	0.60	0.60	0.20	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	41.96	4.45	1.27	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	29.54	6.65	0.00	0.53	0.00	0.53
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	9.47	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	28.41	3.04	1.01	0.51	0.00	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	13.61	0.00	1.60	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	62.84	8.66	1.28	1.92	0.96	1.92
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	45.46	4.47	1.05	1.31	0.26	0.00
nucleus accumbens, adult, pool1	10037-101F1	36.56	5.44	1.78	0.94	0.00	0.19
occipital cortex - adult, donor10196	10172-103C1	26.78	6.18	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	43.21	5.90	2.42	0.81	0.00	0.27
occipital cortex, newborn, donor10223	10355-105E4	17.83	2.91	0.73	0.00	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	34.90	4.46	1.84	0.26	0.52	0.00
occipital lobe, fetal, donor1	10073-102A1	17.59	2.15	0.00	0.00	0.00	0.00
occipital pole, adult, pool1	10036-101E9	40.52	6.78	1.89	0.39	0.24	0.16
olfactory region, adult	10195-103E6	26.94	3.44	1.53	0.38	0.38	0.38
optic nerve, donor1	10277-104E7	24.01	4.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	27.79	1.59	1.03	0.57	0.80	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	57.15	2.34	2.06	0.41	0.27	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	21.84	2.20	1.35	0.34	0.34	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	22.99	1.85	0.58	0.00	0.00	0.46
osteoclastoma cell line:Hs 706.T	10704-109H2	44.39	3.82	0.88	0.88	1.18	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	8.41	3.74	0.00	0.93	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	58.32	4.67	1.06	0.42	0.42	0.21
ovary, adult, pool1	10020-101D2	97.48	27.69	4.89	2.36	3.67	1.66
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	25.11	3.48	0.18	0.18	0.00	0.18
pancreas, adult, donor1	10049-101G4	66.79	14.11	1.88	1.88	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	43.33	1.96	1.12	0.56	1.68	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	101.70	14.31	8.01	1.70	0.34	1.70
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	30.47	1.16	0.00	0.83	0.17	0.17
paracentral gyrus, adult, pool1	10035-101E8	31.58	4.85	1.28	0.18	0.00	0.18
parietal cortex, adult, donor10258	10373-105G4	30.09	2.20	0.73	0.00	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	19.75	1.88	1.88	0.94	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	31.64	6.27	1.43	0.57	0.00	0.29
parietal lobe, adult, pool1	10034-101E7	37.27	5.99	2.03	0.70	0.09	0.00
parietal lobe, fetal, donor1	10072-101I9	20.37	1.94	0.97	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	14.58	0.37	0.37	1.12	0.00	0.00
parotid gland, adult	10199-103F1	156.02	12.95	7.40	2.47	0.62	0.00
penis, adult	10200-103F2	93.46	27.93	5.37	5.37	2.69	3.22
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	14.87	2.05	0.00	0.00	0.37	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	41.09	6.70	4.52	2.62	0.44	0.00
pineal gland - adult, donor10196	10179-103C8	10.32	3.23	0.00	0.65	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	21.32	2.96	1.78	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	18.81	5.02	2.51	0.63	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	73.86	10.12	6.07	0.00	1.01	1.01
pituitary gland, adult, donor10252	10162-103A9	83.91	6.25	5.21	1.56	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	92.79	2.55	3.40	0.00	3.40	0.00
placenta, adult, pool1	10021-101D3	90.73	11.93	4.73	1.29	1.94	0.65
plasma cell leukemia cell line:ARH-77	10840-111E3	43.57	1.46	2.25	0.00	0.13	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	31.91	2.80	1.40	0.47	0.16	0.00
pons, adult, pool1	10033-101E6	30.47	5.34	1.46	0.26	0.00	0.09
postcentral gyrus, adult, pool1	10032-101E5	40.28	5.67	1.74	0.96	0.00	0.52
promyelocytes/myelocytes PMC, donor1	12132-128D8	14.64	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	38.56	11.02	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	52.88	5.97	3.50	1.02	0.29	0.44
prostate cancer cell line:PC-3	10439-106E7	107.81	8.53	3.81	0.91	0.00	0.54
prostate, adult, pool1	10022-101D4	102.57	16.23	5.62	3.08	2.45	1.54
putamen, adult, donor10196	10176-103C5	19.36	2.60	0.47	0.24	0.24	0.00
putamen, adult, donor10252	10152-102I8	19.61	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	16.39	4.37	0.00	0.00	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	24.16	2.17	0.72	0.00	0.24	0.24
putamen, newborn, donor10223	10365-105F5	21.74	6.00	0.75	0.00	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	14.84	0.87	0.58	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	57.03	12.52	0.00	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	125.50	9.12	7.00	1.48	0.00	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	58.40	4.56	1.24	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	146.32	23.46	10.04	2.58	0.50	1.29
retinoblastoma cell line:Y79	10475-106I7	14.03	0.78	0.26	0.00	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	36.76	3.32	0.74	0.49	0.12	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	59.90	10.40	0.84	0.56	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	14.40	1.52	0.00	0.00	0.00	0.76
salivary acinar cells, donor1	11771-123I7	28.16	1.29	0.81	0.00	0.65	0.32
salivary acinar cells, donor2	11772-123I8	59.62	2.75	2.34	0.55	0.96	0.14
salivary acinar cells, donor3	11773-123I9	29.13	2.65	0.66	0.66	0.00	0.66
salivary gland, adult, pool1	10093-102C3	143.56	7.44	6.86	4.00	1.72	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	20.23	2.53	0.25	0.25	0.17	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	17.28	2.12	0.82	0.12	0.35	0.00
seminal vesicle, adult	10201-103F3	55.02	10.05	2.12	1.59	2.65	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	26.96	7.29	4.86	0.73	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	40.51	9.31	3.77	0.50	0.75	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	30.11	9.03	4.01	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	10.21	1.21	0.13	0.00	0.00	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	25.64	1.44	0.66	0.22	0.00	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	24.13	1.55	1.29	0.65	0.13	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	24.12	7.80	2.13	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	62.01	16.79	5.40	0.96	3.48	0.60
skeletal muscle, fetal, donor1	10066-101I3	67.34	13.07	2.01	0.00	1.01	0.00
skin, adult, donor1	10074-102A2	101.78	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	83.32	12.62	2.52	1.26	0.00	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	26.68	3.34	1.67	0.00	0.33	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	54.85	3.47	1.89	0.32	0.32	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	72.47	14.07	1.35	0.39	0.39	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	29.34	2.80	3.13	3.63	0.49	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	13.35	1.29	2.09	0.32	0.16	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	33.12	2.18	1.09	0.22	0.22	0.22
small intestine, adult, pool1	10024-101D6	53.75	9.56	2.15	0.48	2.51	0.60
small intestine, fetal, donor1	10064-101I1	42.01	6.88	0.98	1.23	0.49	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	40.01	5.64	1.03	1.54	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	86.58	15.51	3.62	0.78	0.52	0.78
somatostatinoma cell line:QGP-1	10781-110G7	8.58	1.88	1.07	0.80	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	24.55	5.28	1.15	0.46	0.46	0.00
spinal cord, adult, donor10252	10159-103A6	31.15	4.73	5.13	0.39	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	44.97	7.61	3.46	1.38	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	53.67	10.37	1.83	1.22	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	36.74	5.05	3.21	0.92	0.92	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	29.57	4.03	0.30	0.45	0.15	0.15
spleen, adult, pool1	10025-101D7	74.67	10.79	3.19	1.10	2.64	0.77
spleen, fetal, pool1	10044-101F8	76.91	14.86	3.10	0.72	0.56	0.87
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	15.32	1.45	1.04	0.00	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	13.10	2.09	0.57	0.95	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	94.00	11.18	10.13	3.49	0.35	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	16.42	1.17	0.78	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	35.79	4.61	2.93	0.68	0.23	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	113.10	5.08	2.54	1.27	0.85	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	82.08	7.19	1.69	0.42	0.42	0.00
stomach, fetal, donor1	10062-101H8	23.50	10.68	2.14	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	95.71	11.39	5.13	2.85	1.14	0.57
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	59.40	5.19	2.49	1.04	0.42	0.00
substantia nigra, adult, donor10258	10371-105G2	26.38	3.62	2.59	0.00	0.52	0.52
substantia nigra, newborn, donor10223	10358-105E7	20.49	2.12	0.71	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	60.76	5.73	2.06	1.38	0.23	0.69
temporal lobe, adult, pool1	10031-101E4	46.88	7.12	2.88	0.68	0.08	0.34
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	21.37	2.85	0.00	0.00	1.42	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	21.98	4.83	0.00	0.44	0.00	0.00
tenocyte, donor1	11763-123H8	56.21	9.43	0.70	1.40	0.70	0.70
tenocyte, donor2	11765-123I1	82.02	10.68	2.29	1.14	0.00	0.00
tenocyte, donor3	11768-123I4	62.27	6.30	1.48	0.74	0.00	1.48
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	47.08	4.25	2.89	0.51	0.51	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	24.05	1.23	2.00	0.77	0.77	0.00
teratocarcinoma cell line:PA-1	10807-111A6	44.63	7.75	1.86	0.15	0.00	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	50.02	7.62	3.55	0.63	2.16	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	14.75	3.78	1.13	1.51	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	23.01	3.60	0.98	1.09	0.22	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	47.55	6.51	5.86	1.30	0.33	0.33
testis, adult, pool1	10026-101D8	67.75	16.75	3.22	1.50	11.60	0.54
testis, adult, pool2	10096-102C6	48.72	8.12	0.45	1.80	0.00	0.45
thalamus - adult, donor10196	10168-103B6	19.87	1.10	1.10	0.00	2.21	0.00
thalamus, adult, donor10252	10154-103A1	42.98	6.10	3.44	0.78	0.16	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	16.94	3.08	6.16	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	22.73	3.95	0.66	0.33	0.16	0.00
thalamus, newborn, donor10223	10366-105F6	10.93	1.73	1.15	0.00	0.00	0.00
throat, adult	10209-103G2	95.87	15.23	3.99	2.75	0.75	1.25
throat, fetal, donor1	10061-101H7	59.42	14.32	2.13	1.22	0.61	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	64.59	3.97	0.79	0.20	0.40	0.40
thymus, adult, pool1	10027-101D9	65.61	4.37	4.87	0.80	3.88	0.20
thymus, fetal, pool1	10043-101F7	45.09	4.47	4.05	0.62	0.62	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	61.29	6.65	2.79	0.93	1.46	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	71.94	7.68	3.21	1.68	0.14	0.42
thyroid, adult, pool1	10028-101E1	104.23	21.09	6.25	4.01	2.71	1.03
thyroid, fetal, donor1	10060-101H6	63.02	12.39	3.43	1.05	1.05	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	49.27	6.16	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	79.54	11.86	7.21	1.86	1.63	0.47
tongue, fetal, donor1	10059-101H5	71.33	7.88	1.58	0.79	1.18	0.79
tonsil, adult, pool1	10047-101G2	113.70	8.92	6.71	1.80	0.40	0.40
trachea, adult, pool1	10029-101E2	69.61	10.55	4.09	1.64	0.57	0.82
trachea, fetal, donor1	10058-101H4	50.78	13.08	0.38	1.15	0.00	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	43.58	4.61	2.13	0.71	0.71	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	61.50	4.96	1.72	1.11	0.61	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	47.79	3.13	1.57	0.78	2.04	0.00
tridermal teratoma cell line:HGRT	10694-109G1	15.22	3.81	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	8.89	1.44	0.51	0.08	0.08	0.00
umbilical cord, fetal, donor1	10057-101H3	66.77	12.52	4.17	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	111.08	24.74	7.85	3.41	1.54	1.88
uterus, fetal, donor1	10055-101H1	45.05	15.87	3.58	0.51	0.00	1.02
vagina, adult	10204-103F6	99.51	20.68	4.52	2.58	2.58	0.65
vein, adult	10191-103E2	86.80	15.56	5.04	0.66	2.41	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	25.37	0.53	0.53	0.00	0.00	0.00